Subscribe

Cencora, Inc. (COR)

USD303.30 -2.83 (-0.92%)
US NYSE S&P 500 Healthcare Medical - Distribution
Address 1 West First Avenue 19428-1800
Conshohocken, PA, US
CEO Robert Mauch
IPO 1995-04-04
CIK 1140859 ISIN US03073E1055

Explore sections of this company profile

Also trades on London Stock Exchange · 0HF3.L (USD) New York Stock Exchange · ABC (USD) New York Stock Exchange · COR (USD)
Description

Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Index membership

IndexAddedRemovedStatus
S&P 500 2001-08-29 Active
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD303.30 -2.83 (-0.92%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
0.59
Float Shares
183.99M
Free Float %
94.6%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.47% +2.83% -18.67% -25.67% -28.20% -22.74% -6.27% +52.60% +117.28% +248.93% +8,745.08%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (46 ratings, all time) Buy
Price Targets & DCF
Current price
303.30
Low 331.00 +9.1%
Consensus 389.29 +28.4%
Median 412.00 +35.8%
High 440.00 +45.1%
DCF (Unlevered) 662.08 +118.3%
DCF (Levered) 669.93 +120.9%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 79% Bullish
Rating 2026-05 Change
Strong Buy 3 0
Buy 8 0
Hold 3 0
Sell 0 0
Strong Sell 0 0
Price Target Summary
Period # Analysts Avg Target
Last Month 1
360.00
+18.7%
Last Quarter 4
398.50
+31.4%
Last Year 18
386.33
+27.4%
All Time 43
278.70
-8.1%
Quality scores
Altman Z-Score
4.64
Safe zone
Piotroski F-Score
5 / 9
Average
MOAT Score
5 / 10
Developing
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
5 / 5
High
ROE Score
5 / 5
High
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
2 / 5
Medium
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
  • Revenue growth Medical - Distribution: +5.6%
    +9.3% Q1'26: +3.8% (vs Q1'25)
  • EPS growth Medical - Distribution: +4.9%
    +5.7% Q1'26: +128.3% (vs Q1'25)
  • FCF margin FCF growth · Medical - Distribution: +37.6%
    +0.6% Q1'26: +1.5% (vs Q1'25)
  • EBIT margin Medical - Distribution: +3.0%
    +0.8% Q1'26: +1.7% (vs Q1'25)
  • ROIC Medical - Distribution: +5.7%
    +23.0% Q1'26: +30.6% (vs Q1'25)
  • Share dilution Medical - Distribution: +0.0%
    -2.5% Q1'26: +0.1% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Medical - Distribution: 0.87×
    2.88× Q1'26: 1.93× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.65) × ERP
WACC = 82% × Ke + 18% × Kd (4.0%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Intrinsic value (base): 718.72 Current price: 303.30
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Sep 2011
actual
Sep 2012
actual
Sep 2013
actual
Sep 2014
actual
Sep 2015
actual
Sep 2016
actual
Sep 2017
actual
Sep 2018
actual
Sep 2019
actual
Sep 2020
actual
Sep 2021
actual
Sep 2022
actual
Sep 2023
actual
Sep 2024
actual
Sep 2025
actual
Sep 2026
10 Rev. Ana.
8 EPS Ana.
Sep 2027
10 Rev. Ana.
8 EPS Ana.
Sep 2028
9 Rev. Ana.
3 EPS Ana.
Sep 2029
7 Rev. Ana.
1 EPS Ana.
Sep 2030
8 Rev. Ana.
1 EPS Ana.
Revenue
80.22B
est: 308.44M (+25,907.6%)
79.49B
est: 140.86M (+56,330.0%)
87.96B
est: 163.36M (+53,745.2%)
119.57B
est: 199.62M (+59,799.8%)
135.96B
est: 134.92B (+0.8%)
146.85B
est: 147.21B (-0.2%)
153.14B
est: 154.15B (-0.7%)
167.94B
est: 167.89B (+0.0%)
179.59B
est: 179.18B (+0.2%)
189.89B
est: 188.71B (+0.6%)
213.99B
est: 212.20B (+0.8%)
238.59B
est: 237.88B (+0.3%)
262.17B
est: 276.54B (-5.2%)
293.96B
est: 292.54B (+0.5%)
321.33B
est: 321.05B (+0.1%)
339.06B
332.80B – 341.84B
+5.6% YoY
359.32B
349.75B – 364.33B
+6.0% YoY
383.37B
382.71B – 384.03B
+6.7% YoY
425.66B
416.33B – 434.70B
+11.0% YoY
477.84B
467.36B – 487.98B
+12.3% YoY
EBITDA
1.33B
est: 108.83M (+1,122.8%)
1.40B
est: 117.10M (+1,097.6%)
1.07B
est: 49.89M (+2,035.3%)
939.18M
est: 74.13M (+1,166.9%)
630.77M
est: 119.92M (+426.0%)
1.92B
est: 155.11M (+1,138.0%)
1.49B
est: 223.01M (+568.1%)
1.87B
est: 245.07M (+661.7%)
1.65B
est: 274.74M (+501.0%)
-4.73B
est: 256.07M (-1,948.6%)
2.91B
est: 292.43M (+895.0%)
3.11B
est: 321.67M (+867.7%)
3.41B
est: 3.47B (-1.7%)
3.36B
est: 3.67B (-8.3%)
3.74B
est: 4.03B (-7.2%)
4.25B
4.17B – 4.29B
+5.6% YoY
4.51B
4.39B – 4.57B
+6.0% YoY
4.81B
4.80B – 4.82B
+6.7% YoY
5.34B
5.22B – 5.45B
+11.0% YoY
5.99B
5.86B – 6.12B
+12.3% YoY
EBIT
1.21B
est: -4.92M (+24,676.2%)
1.26B
est: 20.85M (+5,943.6%)
899.51M
est: 20.05M (+4,387.2%)
751.13M
est: 31.58M (+2,278.5%)
380.99M
est: 57.16M (+566.5%)
1.54B
est: 81.82M (+1,776.3%)
1.07B
est: 122.83M (+768.6%)
1.37B
est: 138.26M (+888.8%)
1.16B
est: 144.80M (+702.9%)
-5.14B
est: 123.60M (-4,254.8%)
2.40B
est: 135.53M (+1,674.0%)
2.42B
est: 149.09M (+1,519.9%)
2.44B
est: 2.58B (-5.6%)
2.25B
est: 2.73B (-17.5%)
2.68B
est: 3.00B (-10.6%)
3.16B
3.10B – 3.19B
+5.6% YoY
3.35B
3.26B – 3.40B
+6.0% YoY
3.58B
3.57B – 3.58B
+6.7% YoY
3.97B
3.88B – 4.06B
+11.0% YoY
4.46B
4.36B – 4.55B
+12.3% YoY
Net Income
706.62M
est: -4.46M (+15,932.9%)
718.99M
est: 6.10M (+11,691.2%)
433.71M
est: 10.91M (+3,873.6%)
276.48M
est: 15.81M (+1,648.3%)
-134.89M
est: 30.85M (-537.2%)
1.43B
est: 50.80M (+2,710.6%)
414.48M
est: 73.75M (+462.0%)
1.66B
est: 75.71M (+2,090.4%)
855.37M
est: 77.99M (+996.7%)
-3.40B
est: 69.98M (-4,957.6%)
1.54B
est: 82.85M (+1,758.6%)
1.70B
est: 91.14M (+1,764.0%)
1.75B
est: 1.79B (-2.6%)
1.51B
est: 2.66B (-43.3%)
1.55B
est: 3.11B (-50.0%)
3.46B
3.43B – 3.49B
+11.3% YoY
3.85B
3.76B – 3.93B
+11.1% YoY
4.32B
3.89B – 4.76B
+12.5% YoY
4.77B
4.63B – 4.90B
+10.3% YoY
5.43B
5.28B – 5.58B
+13.9% YoY
SGA
1.20B
est: 74.98M (+1,497.8%)
1.23B
est: 89.33M (+1,276.3%)
1.33B
est: 35.78M (+3,627.8%)
1.59B
est: 44.21M (+3,490.3%)
1.91B
est: 62.95M (+2,930.8%)
2.09B
est: 65.34M (+3,100.4%)
2.13B
est: 78.51M (+2,611.5%)
2.46B
est: 86.27M (+2,751.8%)
2.66B
est: 101.60M (+2,521.6%)
2.77B
est: 92.37M (+2,895.8%)
3.59B
est: 100.31M (+3,483.0%)
4.85B
est: 110.34M (+4,294.4%)
5.31B
est: 5.36B (-0.9%)
5.66B
est: 5.67B (-0.1%)
6.49B
est: 6.22B (+4.4%)
6.57B
6.45B – 6.62B
+5.6% YoY
6.96B
6.77B – 7.06B
+6.0% YoY
7.43B
7.41B – 7.44B
+6.7% YoY
8.24B
8.06B – 8.42B
+11.0% YoY
9.25B
9.05B – 9.45B
+12.3% YoY
EPS
2.59
est: -0.63 (+514.4%)
2.84
est: 0.04 (+8,014.3%)
1.88
est: 0.20 (+864.1%)
1.22
est: 0.37 (+234.2%)
-0.62
est: 4.97 (-112.5%)
6.73
est: 5.55 (+21.4%)
1.67
est: 5.88 (-71.6%)
7.61
est: 6.48 (+17.4%)
4.07
est: 7.05 (-42.3%)
-16.60
est: 7.87 (-311.0%)
7.48
est: 9.23 (-19.0%)
8.15
est: 11.00 (-25.9%)
8.62
est: 9.23 (-6.6%)
7.60
est: 13.65 (-44.3%)
8.02
est: 15.94 (-49.7%)
17.74
17.58 – 17.89
+11.3% YoY
19.70
19.28 – 20.12
+11.0% YoY
21.86
19.93 – 24.38
+11.0% YoY
24.44
23.74 – 25.11
+11.8% YoY
27.84
27.05 – 28.61
+13.9% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-12 B+ 3/5 5/5 5/5 4/5 1/5 2/5 1/5
2026-05-11 B+ 3/5 5/5 5/5 4/5 1/5 2/5 1/5
2026-05-08 B+ 3/5 5/5 5/5 4/5 1/5 2/5 1/5
2026-05-07 B+ 3/5 5/5 5/5 4/5 1/5 2/5 1/5
2026-05-06 B+ 3/5 5/5 5/5 4/5 1/5 2/5 1/5
2026-05-05 B+ 3/5 5/5 5/5 4/5 1/5 2/5 1/5
2026-05-04 B+ 3/5 5/5 5/5 4/5 1/5 2/5 1/5
2026-05-01 B+ 3/5 5/5 5/5 4/5 1/5 2/5 1/5
2026-04-30 B+ 3/5 5/5 5/5 4/5 1/5 2/5 1/5
2026-04-29 B+ 3/5 5/5 5/5 4/5 1/5 2/5 1/5
2026-04-28 B+ 3/5 5/5 5/5 4/5 1/5 2/5 1/5
2026-04-27 B+ 3/5 5/5 5/5 4/5 1/5 2/5 1/5
2026-04-24 B+ 3/5 5/5 5/5 4/5 1/5 2/5 1/5
2026-04-23 B 3/5 5/5 5/5 4/5 1/5 1/5 1/5
2026-04-22 B 3/5 5/5 5/5 4/5 1/5 1/5 1/5
2026-04-21 B 3/5 5/5 5/5 4/5 1/5 1/5 1/5
2026-04-20 B 3/5 5/5 5/5 4/5 1/5 1/5 1/5
2026-04-17 B 3/5 5/5 5/5 4/5 1/5 1/5 1/5
2026-04-16 B 3/5 5/5 5/5 4/5 1/5 1/5 1/5
2026-04-15 B 3/5 5/5 5/5 4/5 1/5 1/5 1/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
1.78B
OE per share TTM
9.22
Owner's Yield
3.62%
Maintenance CapEx ratio
7.95%
Maint CapEx / Avg PPE
1.2%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
511
Total invested
2.78B
Insider transactions (90d)
3
Beneficial owners (>5%)
36
Beneficial owners (>5%)
# Reporting person Amount owned % of class Sole voting Shared voting Sole dispositive Shared dispositive Type Citizenship Filing date SEC filing
1 WBA Investments, Inc. 33.09M 16.38% 33.09M 10.00 CO 2023-06-20
2 Walgreens Boots Alliance Holdings LLC 33.09M 16.38% 33.09M 33.09M OO 2023-06-20
3 Walgreens Boots Alliance, Inc. 33.09M 16.38% 33.09M 10.00 HC, CO 2023-06-20
4 BlackRock for purposes of Schedule 13G filings. 26.54M 9.21% 26.54M 26.54M HC Delaware 2010-01-29
5 (1) BlackRock, Inc. 13.04M 6.30% 11.46M 13.04M HC Delaware 2022-02-03
6 (on behalf of its investment advisory subsidiaries - See Item 7) 8.27M 5.30% 8.27M IA, HC NUMBER OF SHARES BENEFICALLY OWNED BY EACH REPORTING PERSON WITH 2009-02-10
7 04-2747644 2.43M 5.70% 2.41M 2.43M IA Delaware 2021-02-11
8 Edward C. Johnson 3d 2.41M 11.40% 2.41M IN Delaware 2012-11-13
9 FMR LLC 2.41M 11.40% 245.8K 2.41M HC Delaware 2012-11-13
10 The Vanguard Group Inc. - 23-1945930 2.00M 10.05% 1.97M 24.3K IA Pennsylvania 2011-09-08
11 LLC                     04-3519872 1.75M 8.20% 1.58M 1.75M IA Delaware 2014-02-06
12 AB Acquisitions Holdings Limited 0.00% 10.00 OO Gibraltar 2015-01-23
13 Alliance Santé Participations S.A. 0.00% 10.00 CO Grand Duchy of Luxembourg 2015-01-23
14 George R. Roberts 0.00% 10.00 IN United States 2015-01-23
15 Henry R. Kravis 0.00% 10.00 IN United States 2015-01-23
16 Janus Capital Management LLC 0.00% IA, HC Delaware 2003-12-11
17 KKR & Co. L.P. 0.00% 10.00 PN Cayman Islands 2015-01-23
18 KKR 2006 Fund (Overseas), Limited Partnership 0.00% 10.00 PN Cayman Islands 2015-01-23
19 KKR 2006 Limited 0.00% 10.00 CO Cayman Islands 2015-01-23
20 KKR Associates 2006 (Overseas), Limited Partnership 0.00% 10.00 PN Cayman Islands 2015-01-23
21 KKR Associates Europe II, Limited Partnership 0.00% 10.00 PN Cayman Islands 2015-01-23
22 KKR Europe II Limited 0.00% 10.00 CO Cayman Islands 2015-01-23
23 KKR European Fund II, Limited Partnership 0.00% 10.00 PN Cayman Islands 2015-01-23
24 KKR Fund Holdings GP Limited 0.00% 10.00 CO Cayman Islands 2015-01-23
25 KKR Fund Holdings L.P. 0.00% 10.00 PN Cayman Islands 2015-01-23
26 KKR Group Holdings L.P. 0.00% 10.00 PN Cayman Islands 2015-01-23
27 KKR Group Limited 0.00% 10.00 CO Cayman Islands 2015-01-23
28 KKR Management LLC 0.00% 10.00 OO Delaware 2015-01-23
29 KKR PEI Associates, L.P. 0.00% 10.00 PN Guernsey, Channel Islands 2015-01-23
30 KKR PEI GP Limited 0.00% 10.00 CO Cayman Islands 2015-01-23
31 KKR PEI Investments, L.P. 0.00% 10.00 PN Guernsey, Channel Islands 2015-01-23
32 KKR Sprint Limited 0.00% 10.00 CO Cayman Islands 2015-01-23
33 KKR Sprint (European II) Limited 0.00% 10.00 CO Cayman Islands 2015-01-23
34 KKR Sprint (KPE) Limited 0.00% 10.00 CO Cayman Islands 2015-01-23
35 NEWCIP S.A. 0.00% 10.00 CO Grand Duchy of Luxembourg 2015-01-23
36 Stefano Pessina 0.00% 10.00 IN Monaco 2015-01-23

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2026 Q1
Investors holding
511
-993 vs prev Q
New positions
37
Closed positions
987
Increased
228
Reduced
177
Put/Call ratio
0.00
Calls held
Puts held
4.00
Top institutional holders
# Investor Shares / Δ Mkt value / Δ Own% / Δ Weight% / Δ Avg px / Perf. Hold / Status
1 VANGUARD GROUP INC 23.62M +221.6K (+0.9%) 7.98B +664.9M (+9.1%) 12.16% +0.089 pp 0.12% +0.006 pp USD102.16 +230.6% 84 qtrs
2 BLACKROCK, INC. 20.29M +508.6K (+2.6%) 6.85B +670.6M (+10.8%) 10.45% +0.241 pp 0.12% +0.008 pp USD239.30 +41.1% 6 qtrs
3 STATE STREET CORP 9.31M +115.2K (+1.3%) 3.14B +270.7M (+9.4%) 4.79% +0.050 pp 0.11% +0.006 pp USD144.82 +133.2% 41 qtrs
4 PRICE T ROWE ASSOCIATES INC /MD/ 6.99M -731.1K (-9.5%) 2.36B -52.1M (-2.2%) 3.60% -0.385 pp 0.25% -0.004 pp USD175.07 +92.9% 75 qtrs
5 T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 6.70M +4.1M (+160.1%) 2.26B +1.5B (+181.1%) 3.45% +2.121 pp 1.43% +0.936 pp USD324.85 +4.0% 5 qtrs
6 FMR LLC 5.46M +2.1M (+64.9%) 1.84B +809.1M (+78.2%) 2.81% +1.103 pp 0.09% +0.040 pp USD267.12 +26.4% 70 qtrs
7 GEODE CAPITAL MANAGEMENT, LLC 5.46M +169.1K (+3.2%) 1.84B +196.1M (+11.9%) 2.81% +0.081 pp 0.11% +0.009 pp USD151.06 +123.6% 78 qtrs
8 JPMORGAN CHASE & CO 4.98M +304.8K (+6.5%) 1.68B +220.9M (+15.1%) 2.57% +0.152 pp 0.11% +0.018 pp USD161.43 +109.2% 51 qtrs
9 WELLINGTON MANAGEMENT GROUP LLP 4.54M +564.9K (+14.2%) 1.53B +290.9M (+23.4%) 2.34% +0.287 pp 0.27% +0.051 pp USD220.00 +53.5% 69 qtrs
10 BOSTON PARTNERS 4.20M -312.6K (-6.9%) 1.42B +9.3M (+0.7%) 2.16% -0.166 pp 1.47% +0.022 pp USD138.76 +143.4% 29 qtrs
11 INVESCO LTD. 3.92M -90.5K (-2.3%) 1.32B +70.5M (+5.6%) 2.02% -0.051 pp 0.20% +0.006 pp USD191.04 +76.8% 57 qtrs
12 BANK OF AMERICA CORP /DE/ 3.87M -93.4K (-2.4%) 1.31B +68.4M (+5.5%) 1.99% -0.052 pp 0.10% +0.011 pp USD220.76 +53.0% 52 qtrs
13 MORGAN STANLEY 2.92M -415.9K (-12.4%) 987.85M -56.2M (-5.4%) 1.51% -0.218 pp 0.06% -0.004 pp USD171.41 +97.0% 51 qtrs
14 CAPITAL RESEARCH GLOBAL INVESTORS 2.75M +88.5K (+3.3%) 928.67M +97.0M (+11.7%) 1.42% +0.043 pp 0.17% +0.015 pp USD182.69 +84.9% 19 qtrs
15 NORGES BANK 2.44M +2.4M (+100.0%) 822.51M +822.5M (+100.0%) 1.25% +1.254 pp 0.09% +0.088 pp USD337.75 +0.0% 1 qtrs NEW
16 AMUNDI 2.23M +571.8K (+34.5%) 753.30M +246.9M (+48.8%) 1.15% +0.293 pp 0.20% +0.042 pp USD235.06 +43.7% 19 qtrs
17 NORTHERN TRUST CORP 2.22M -48.7K (-2.1%) 751.06M +40.8M (+5.8%) 1.15% -0.028 pp 0.10% +0.005 pp USD110.12 +206.7% 51 qtrs
18 GOLDMAN SACHS GROUP INC 2.13M +525.2K (+32.8%) 718.76M +217.8M (+43.5%) 1.10% +0.269 pp 0.09% +0.027 pp USD226.67 +49.0% 73 qtrs
19 UBS ASSET MANAGEMENT AMERICAS INC 1.58M +106.0K (+7.2%) 534.28M +73.0M (+15.8%) 0.81% +0.053 pp 0.11% +0.013 pp USD294.95 +14.5% 90 qtrs
20 DIMENSIONAL FUND ADVISORS LP 1.51M +38.3K (+2.6%) 511.20M +50.2M (+10.9%) 0.78% +0.018 pp 0.11% +0.008 pp USD137.48 +145.7% 51 qtrs
21 WELLS FARGO & COMPANY/MN 1.38M +2.7K (+0.2%) 466.07M +35.6M (+8.3%) 0.71% 0.000 pp 0.08% +0.003 pp USD114.58 +194.8% 57 qtrs
22 BESSEMER GROUP INC 1.37M -523.7K (-27.7%) 461.05M -129.2M (-21.9%) 0.70% -0.272 pp 0.71% -0.195 pp USD156.58 +115.7% 39 qtrs
23 LEGAL & GENERAL GROUP PLC 1.35M -91.5K (-6.3%) 456.05M +5.5M (+1.2%) 0.70% -0.049 pp 0.10% +0.000 pp USD117.47 +187.5% 75 qtrs
24 ROYAL BANK OF CANADA 1.33M +219.1K (+19.7%) 449.04M +102.0M (+29.4%) 0.68% +0.112 pp 0.07% +0.016 pp USD278.87 +21.1% 51 qtrs
25 NORDEA INVESTMENT MANAGEMENT AB 1.26M +45.7K (+3.8%) 426.72M +52.9M (+14.1%) 0.65% +0.022 pp 0.37% +0.039 pp USD233.07 +44.9% 83 qtrs
26 ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.25M +229.3K (+22.5%) 421.50M +103.1M (+32.4%) 0.64% +0.117 pp 0.25% +0.046 pp USD221.79 +52.3% 26 qtrs
27 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.22M +11.6K (+1.0%) 413.20M +34.5M (+9.1%) 0.63% +0.005 pp 0.06% +0.004 pp USD143.78 +134.9% 98 qtrs
28 UBS GROUP AG 1.12M +407.4K (+57.0%) 379.20M +155.6M (+69.6%) 0.58% +0.209 pp 0.06% +0.027 pp USD257.33 +31.3% 45 qtrs
29 ARTISAN PARTNERS LIMITED PARTNERSHIP 1.12M -160.9K (-12.6%) 377.83M -22.1M (-5.5%) 0.58% -0.084 pp 0.57% -0.002 pp USD299.85 +12.6% 3 qtrs
30 BANK OF NEW YORK MELLON CORP 1.05M -34.5K (-3.2%) 355.62M +15.8M (+4.6%) 0.54% -0.019 pp 0.06% -0.003 pp USD83.11 +306.4% 66 qtrs
31 RAYMOND JAMES FINANCIAL INC 971.6K -95.7K (-9.0%) 329.51M -4.1M (-1.2%) 0.50% -0.050 pp 0.10% -0.005 pp USD224.68 +50.3% 5 qtrs
32 DEUTSCHE BANK AG\ 920.8K -232.4K (-20.2%) 310.99M -49.4M (-13.7%) 0.47% -0.121 pp 0.10% -0.020 pp USD228.53 +47.8% 50 qtrs
33 MANUFACTURERS LIFE INSURANCE COMPANY, THE 919.6K -248.2K (-21.3%) 310.75M -54.2M (-14.9%) 0.47% -0.129 pp 0.26% -0.045 pp USD228.11 +48.1% 94 qtrs
34 HOLOCENE ADVISORS, LP 897.3K -204.6K (-18.6%) 303.06M -41.3M (-12.0%) 0.46% -0.107 pp 0.64% -0.148 pp USD274.39 +23.1% 10 qtrs
35 TD ASSET MANAGEMENT INC 887.8K +569.3K (+178.7%) 299.87M +200.3M (+201.2%) 0.46% +0.293 pp 0.24% +0.160 pp USD267.52 +26.3% 51 qtrs
36 SUMITOMO MITSUI TRUST HOLDINGS, INC. 877.9K -35.8K (-3.9%) 296.51M +10.9M (+3.8%) 0.45% -0.019 pp 0.17% +0.010 pp USD155.53 +117.2% 59 qtrs
37 CARMIGNAC GESTION 875.1K -751.0 (-0.1%) 295.57M +21.9M (+8.0%) 0.45% -0.001 pp 4.00% -0.082 pp USD228.65 +47.7% 7 qtrs
38 ALLIANCEBERNSTEIN L.P. 865.8K -24.0K (-2.7%) 292.42M +14.3M (+5.2%) 0.45% -0.013 pp 0.09% +0.005 pp USD172.04 +96.3% 61 qtrs
39 BANK OF MONTREAL /CAN/ 857.6K +595.7K (+227.5%) 289.66M +207.8M (+253.9%) 0.44% +0.307 pp 0.10% +0.069 pp USD298.55 +13.1% 51 qtrs
40 NUVEEN, LLC 804.6K +9.9K (+1.3%) 271.75M +23.4M (+9.4%) 0.41% +0.004 pp 0.07% +0.006 pp USD283.76 +19.0% 4 qtrs
41 NATIONAL PENSION SERVICE 720.4K +42.7K (+6.3%) 243.31M +31.5M (+14.9%) 0.37% +0.021 pp 0.18% +0.016 pp USD225.62 +49.7% 46 qtrs
42 AMERICAN CENTURY COMPANIES INC 697.2K -265.3K (-27.6%) 235.47M -65.3M (-21.7%) 0.36% -0.138 pp 0.12% -0.035 pp USD226.93 +48.8% 25 qtrs
43 NEUBERGER BERMAN GROUP LLC 684.5K +7.3K (+1.1%) 231.29M +19.9M (+9.4%) 0.35% +0.003 pp 0.17% +0.018 pp USD150.55 +124.3% 37 qtrs
44 FEDERATED HERMES, INC. 677.7K -100.2K (-12.9%) 228.90M -14.2M (-5.9%) 0.35% -0.052 pp 0.38% -0.047 pp USD243.66 +38.6% 54 qtrs
45 SWEDBANK AB 672.5K -726.6K (-51.9%) 227.15M -210.1M (-48.1%) 0.35% -0.376 pp 0.22% -0.224 pp USD173.35 +94.8% 20 qtrs
46 AMERIPRISE FINANCIAL INC 656.9K +7.0K (+1.1%) 221.85M +18.7M (+9.2%) 0.34% +0.003 pp 0.05% +0.004 pp USD268.76 +25.7% 55 qtrs
47 FIRST TRUST ADVISORS LP 652.1K -61.4K (-8.6%) 220.24M -2.8M (-1.2%) 0.34% -0.032 pp 0.16% -0.006 pp USD143.14 +136.0% 51 qtrs
48 QUBE RESEARCH & TECHNOLOGIES LTD 644.9K +33.5K (+5.5%) 217.81M +26.7M (+14.0%) 0.33% +0.017 pp 0.22% +0.024 pp USD250.41 +34.9% 10 qtrs
49 MAWER INVESTMENT MANAGEMENT LTD. 618.3K -32.4K (-5.0%) 208.83M +5.5M (+2.7%) 0.32% -0.017 pp 1.17% +0.114 pp USD138.75 +143.4% 36 qtrs
50 AQR CAPITAL MANAGEMENT LLC 576.4K -226.3K (-28.2%) 194.67M -53.0M (-21.4%) 0.30% -0.117 pp 0.10% -0.057 pp USD212.26 +59.1% 27 qtrs
51 CAISSE DE DEPOT ET PLACEMENT DU QUEBEC 575.9K -307.6K (-34.8%) 194.50M -81.6M (-29.6%) 0.30% -0.159 pp 0.33% -0.168 pp USD263.74 +28.1% 51 qtrs
52 MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 568.1K -89.6K (-13.6%) 191.88M -13.7M (-6.7%) 0.29% -0.047 pp 0.06% -0.002 pp USD102.12 +230.7% 51 qtrs
53 PACER ADVISORS, INC. 561.7K +541.5K (+2,682.3%) 189.70M +183.4M (+2,906.8%) 0.29% +0.279 pp 0.48% +0.469 pp USD336.35 +0.4% 44 qtrs
54 SEI INVESTMENTS CO 506.9K -21.7K (-4.1%) 171.20M +6.0M (+3.6%) 0.26% -0.012 pp 0.17% -0.009 pp USD214.15 +57.7% 45 qtrs
55 SWISS NATIONAL BANK 504.7K -26.0K (-4.9%) 170.46M +4.6M (+2.8%) 0.26% -0.014 pp 0.10% +0.005 pp USD120.11 +181.2% 51 qtrs
56 CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 494.7K -94.1K (-16.0%) 167.08M -16.9M (-9.2%) 0.25% -0.049 pp 0.10% -0.015 pp USD141.94 +138.0% 58 qtrs
57 ENVESTNET ASSET MANAGEMENT INC 477.5K -47.6K (-9.1%) 161.28M -2.8M (-1.7%) 0.25% -0.025 pp 0.05% +0.001 pp USD161.82 +108.7% 51 qtrs
58 BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. 434.1K +253.7K (+140.6%) 146.65M +90.8M (+162.6%) 0.22% +0.130 pp 0.17% +0.024 pp USD293.33 +15.1% 51 qtrs
59 RHUMBLINE ADVISERS 432.7K +2.5K (+0.6%) 146.14M +11.7M (+8.7%) 0.22% +0.001 pp 0.12% +0.010 pp USD112.63 +199.9% 52 qtrs
60 FRANKLIN RESOURCES INC 432.5K -9.6K (-2.2%) 146.09M +7.9M (+5.7%) 0.22% -0.005 pp 0.04% +0.001 pp USD238.13 +41.8% 51 qtrs
61 TIMESSQUARE CAPITAL MANAGEMENT, LLC 423.0K -20.6K (-4.6%) 142.88M +4.2M (+3.1%) 0.22% -0.011 pp 2.15% +0.170 pp USD112.08 +201.3% 24 qtrs
62 DEKABANK DEUTSCHE GIROZENTRALE 543.0K +— (+0.0%) 142.80M -23.1M (-13.9%) 0.28% -0.001 pp 0.25% -0.032 pp USD161.92 +108.6% 66 qtrs
63 BNP PARIBAS ARBITRAGE, SNC 403.3K -144.6K (-26.4%) 136.21M -35.0M (-20.5%) 0.21% -0.075 pp 0.06% -0.030 pp USD231.28 +46.0% 51 qtrs
64 MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. 400.6K +19.8K (+5.2%) 135.75M +16.7M (+14.1%) 0.21% +0.010 pp 0.09% +0.006 pp USD214.12 +57.7% 58 qtrs
65 JANUS HENDERSON GROUP PLC 397.1K -3.7K (-0.9%) 134.12M +8.9M (+7.1%) 0.20% -0.002 pp 0.06% +0.003 pp USD187.28 +80.3% 88 qtrs
66 HSBC HOLDINGS PLC 394.1K -73.7K (-15.8%) 133.24M -12.9M (-8.8%) 0.20% -0.039 pp 0.07% -0.013 pp USD200.45 +68.5% 56 qtrs
67 BARCLAYS PLC 388.5K -105.2K (-21.3%) 131.21M +20.1M (+18.1%) 0.20% -0.055 pp 0.03% +0.003 pp USD186.24 +81.4% 51 qtrs
68 ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC 383.1K -40.6K (-9.6%) 129.81M -2.3M (-1.7%) 0.20% -0.021 pp 0.21% -0.002 pp USD276.04 +22.4% 17 qtrs
69 TRUIST FINANCIAL CORP 378.7K -23.6K (-5.9%) 127.91M +2.2M (+1.7%) 0.20% -0.013 pp 0.17% +0.001 pp USD161.09 +109.7% 51 qtrs
70 MILLENNIUM MANAGEMENT LLC 374.4K -611.5K (-62.0%) 126.45M -181.7M (-59.0%) 0.19% -0.316 pp 0.05% -0.078 pp USD249.13 +35.6% 52 qtrs
71 JOHNSON INVESTMENT COUNSEL INC 369.0K -19.2K (-5.0%) 124.64M +3.3M (+2.7%) 0.19% -0.010 pp 1.02% +0.005 pp USD167.72 +101.4% 51 qtrs
72 SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) 367.1K +71.3K (+24.1%) 123.99M +31.6M (+34.1%) 0.19% +0.036 pp 0.50% +0.126 pp USD247.33 +36.6% 40 qtrs
73 D. E. SHAW & CO., INC. 359.1K +128.8K (+55.9%) 121.30M +49.3M (+68.5%) 0.18% +0.066 pp 0.07% +0.026 pp USD289.71 +16.6% 33 qtrs
74 VOYA INVESTMENT MANAGEMENT LLC 359.1K -14.4K (-3.8%) 121.29M +4.6M (+3.9%) 0.18% -0.008 pp 0.12% +0.003 pp USD207.98 +62.4% 51 qtrs
75 JANE STREET GROUP, LLC 348.1K +7.7K (+2.3%) 117.57M +11.2M (+10.5%) 0.18% +0.004 pp 0.02% +0.002 pp USD228.28 +48.0% 6 qtrs
76 HANDELSBANKEN FONDER AB 347.3K +7.5K (+2.2%) 117.30M +11.1M (+10.4%) 0.18% +0.004 pp 0.35% +0.017 pp USD143.57 +135.3% 23 qtrs
77 GREAT LAKES ADVISORS, LLC 339.4K -3.0K (-0.9%) 114.63M +7.6M (+7.1%) 0.17% -0.002 pp 0.93% +0.041 pp USD185.58 +82.0% 53 qtrs
78 WORLDQUANT MILLENNIUM ADVISORS LLC 331.6K +328.5K (+10,574.0%) 112.01M +111.0M (+11,435.3%) 0.17% +0.169 pp 0.43% +0.430 pp USD337.47 +0.1% 10 qtrs
79 SG AMERICAS SECURITIES, LLC 319.5K +302.3K (+1,750.8%) 107.93M +102.5M (+1,900.1%) 0.16% +0.156 pp 0.14% +0.120 pp USD332.23 +1.7% 51 qtrs
80 WESTFIELD CAPITAL MANAGEMENT CO LP 319.2K -6.4K (-2.0%) 107.81M +6.0M (+5.9%) 0.16% -0.004 pp 0.45% +0.022 pp USD284.11 +18.9% 4 qtrs
81 CITADEL ADVISORS LLC 294.0K +25.4K (+9.5%) 99.30M +15.4M (+18.3%) 0.15% +0.013 pp 0.01% +0.002 pp USD196.05 +72.3% 38 qtrs
82 ZURCHER KANTONALBANK (ZURICH CANTONALBANK) 289.4K +179.1K (+162.4%) 97.73M +63.3M (+183.6%) 0.15% +0.092 pp 0.21% +0.132 pp USD280.20 +20.5% 57 qtrs
83 CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 289.3K -10.0K (-3.3%) 97.72M +4.2M (+4.5%) 0.15% -0.006 pp 0.10% +0.002 pp USD99.51 +239.4% 52 qtrs
84 LPL FINANCIAL LLC 289.0K +23.9K (+9.0%) 97.60M +14.7M (+17.8%) 0.15% +0.012 pp 0.03% +0.003 pp USD193.32 +74.7% 37 qtrs
85 WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 277.8K -2.1K (-0.8%) 96.17M +9.8M (+11.3%) 0.14% -0.001 pp 0.13% 0.000 pp USD185.16 +82.4% 12 qtrs
86 CORNERSTONE INVESTMENT PARTNERS, LLC 283.9K -7.4K (-2.5%) 95.90M +4.9M (+5.3%) 0.15% -0.004 pp 3.72% -0.086 pp USD125.02 +170.2% 23 qtrs
87 DANSKE BANK A/S 274.4K -31.6K (-10.3%) 92.67M -2.9M (-3.1%) 0.14% -0.017 pp 0.22% -0.022 pp USD266.58 +26.7% 8 qtrs
88 FIRST MANHATTAN CO. LLC. 266.7K -7.7K (-2.8%) 90.07M +4.3M (+5.0%) 0.14% -0.004 pp 0.24% +0.010 pp USD115.89 +191.4% 51 qtrs
89 SUSQUEHANNA INTERNATIONAL GROUP, LLP 265.6K +142.1K (+115.1%) 89.71M +51.1M (+132.4%) 0.14% +0.073 pp 0.01% +0.006 pp USD278.47 +21.3% 51 qtrs
90 CLARK CAPITAL MANAGEMENT GROUP, INC. 253.6K +2.2K (+0.9%) 85.67M +7.1M (+9.0%) 0.13% +0.001 pp 0.53% +0.034 pp USD177.32 +90.5% 14 qtrs
91 PRINCIPAL FINANCIAL GROUP INC 253.0K +4.8K (+1.9%) 85.44M +7.9M (+10.2%) 0.13% +0.002 pp 0.04% +0.005 pp USD141.81 +138.2% 81 qtrs
92 CIBC PRIVATE WEALTH GROUP, LLC 251.9K -14.1K (-5.3%) 85.07M +1.9M (+2.3%) 0.13% -0.008 pp 0.14% +0.002 pp USD179.64 +88.0% 48 qtrs
93 GREAT WEST LIFE ASSURANCE CO /CAN/ 251.7K -38.5K (-13.3%) 85.06M -4.3M (-4.9%) 0.13% -0.020 pp 0.15% +0.020 pp USD126.84 +166.3% 52 qtrs
94 FIL LTD 247.6K +12.9K (+5.5%) 83.63M +10.3M (+14.0%) 0.13% +0.006 pp 0.06% +0.005 pp USD117.84 +186.6% 36 qtrs
95 ACADIAN ASSET MANAGEMENT LLC 245.9K +12.1K (+5.2%) 83.04M +10.0M (+13.7%) 0.13% +0.006 pp 0.14% +0.009 pp USD294.56 +14.7% 23 qtrs
96 ASSENAGON ASSET MANAGEMENT S.A. 243.5K -109.5K (-31.0%) 82.25M -28.1M (-25.5%) 0.13% -0.057 pp 0.11% -0.038 pp USD308.73 +9.4% 37 qtrs
97 THRIVENT FINANCIAL FOR LUTHERANS 240.2K -5.0K (-2.1%) 81.13M +4.5M (+5.8%) 0.12% -0.003 pp 0.14% -0.007 pp USD261.01 +29.4% 74 qtrs
98 EARNEST PARTNERS LLC 234.2K -899.0 (-0.4%) 79.10M +5.6M (+7.7%) 0.12% -0.001 pp 0.34% +0.020 pp USD129.26 +161.3% 51 qtrs
Ownership breakdown by holder

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
1
Sells
0
Shares acquired
3.9K
Shares disposed
Cash buys
Cash sales
Net activity
+3,936
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2026-05-01 Tyler Lauren M Director A-Award A Common Stock 99 304.00 30.1K 3,809 D
2026-05-01 NALLY DENNIS M Director A-Award A Common Stock 116 304.00 35.3K 13,075 D
2026-05-01 Cooper Ellen Director A-Award A Common Stock 99 304.00 30.1K 796 D
2026-04-01 Krikorian Lazarus Officer A-Award A Restricted Stock Units 3,936 0.00 3,936 D
2026-03-11 Cleary James F Officer F-InKind D Common Stock 5,409 350.30 1.89M 160,357 D
2026-03-11 Campbell Elizabeth S Officer F-InKind D Common Stock 5,842 350.30 2.05M 30,706 D
2026-03-11 Battaglia Silvana Officer F-InKind D Common Stock 3,673 350.30 1.29M 23,566 D
2026-03-05 Tyler Lauren M Director A-Award A Common Stock 557 359.28 200.1K 3,710 D
2026-03-05 Ryerkerk Lori Director A-Award A Common Stock 557 359.28 200.1K 1,073 D
2026-03-05 NALLY DENNIS M Director A-Award A Common Stock 557 359.28 200.1K 12,959 D
2026-03-05 Miller Redonda Director A-Award A Common Stock 557 359.28 200.1K 3,751 D
2026-03-05 Kim Lorence H. Director A-Award A Common Stock 557 359.28 200.1K 4,081 D
2026-03-05 GREENBERG LON R Director A-Award A Common Stock 557 359.28 200.1K 18,408 D
2026-03-05 DURCAN DERMOT MARK Director A-Award A Common Stock 905 359.28 325.1K 23,767 D
2026-03-05 Cooper Ellen Director A-Award A Common Stock 557 359.28 200.1K 697 D
2026-03-05 Clyburn Frank Director A-Award A Common Stock 557 359.28 200.1K 1,724 D
2026-03-05 Baumann Werner Director A-Award A Common Stock 557 359.28 200.1K 3,687 D
2026-02-20 Mauch Robert P. Director / Officer M-Exempt A Common Stock 3,762 86.09 323.9K 69,155 D
2026-02-18 Mauch Robert P. Director / Officer S-Sale D Common Stock 1,333 359.46 479.2K 65,393 D
2026-01-30 Tyler Lauren M Director A-Award A Common Stock 84 359.22 30.2K 3,153 D
2026-01-30 NALLY DENNIS M Director A-Award A Common Stock 98 359.22 35.2K 12,402 D
2026-01-30 Cooper Ellen Director A-Award A Common Stock 69 359.22 24.8K 74 D
2026-01-20 Mauch Robert P. Director / Officer S-Sale D Common Stock 5,096 354.73 1.81M 66,726 D
2026-01-20 Cooper Ellen Director 0 0.00 0
2025-12-31 Campbell Elizabeth S Officer A-Award A Common Stock 34 287.09 9.6K 23,925 D
2025-12-31 Battaglia Silvana Officer A-Award A Common Stock 27 287.09 7.9K 18,824 D
2025-12-19 Campbell Elizabeth S Officer S-Sale D Common Stock 3,351 342.10 1.15M 23,891 D
2025-12-19 Battaglia Silvana Officer S-Sale D Common Stock 1,677 345.00 578.6K 18,796 D
2025-12-18 Mauch Robert P. Director / Officer M-Exempt D Non-qualified Stock Option (Right to Buy) 3,763 86.09 324.0K 7,525 D
2025-12-17 NALLY DENNIS M Director G-Gift D Common Stock 1,173 0.00 12,304 D
2025-12-17 Mauch Robert P. Director / Officer G-Gift D Common Stock 3,000 0.00 66,392 D
2025-12-17 Krikorian Lazarus Officer S-Sale D Common Stock 4,031 343.24 1.38M 17,154 D
2025-12-17 Cleary James F Officer M-Exempt A Common Stock 45,154 86.09 3.89M 180,095 D
2025-12-15 Mauch Robert P. Director / Officer M-Exempt A Common Stock 638 0.00 70,030 D
2025-12-15 Krikorian Lazarus Officer F-InKind D Common Stock 91 350.32 31.9K 21,185 D
2025-12-15 Cleary James F Officer F-InKind D Common Stock 199 350.32 69.7K 134,941 D
2025-11-20 Verma Pawan Officer F-InKind D Common Stock 1,010 362.07 365.7K 5,148 D
2025-11-20 Mauch Robert P. Director / Officer M-Exempt D Restricted Stock Units 5,790 0.00 13,158 D
2025-11-20 Krikorian Lazarus Officer F-InKind D Common Stock 421 362.07 152.4K 21,185 D
2025-11-20 Cleary James F Officer F-InKind D Common Stock 824 362.07 298.3K 134,941 D
2025-11-20 Campbell Elizabeth S Officer M-Exempt D Restricted Stock Units 1,590 0.00 3,180 D
2025-11-20 Battaglia Silvana Officer M-Exempt A Common Stock 932 0.00 20,879 D
2025-11-18 Mauch Robert P. Director / Officer M-Exempt A Common Stock 3,763 86.09 324.0K 70,842 D
2025-11-13 Mauch Robert P. Director / Officer A-Award A Common Stock 42,944 0.00 85,756 D
2025-11-13 Krikorian Lazarus Officer A-Award A Common Stock 2,434 0.00 21,642 D
2025-11-13 Cleary James F Officer A-Award A Common Stock 30,062 0.00 147,790 D
2025-11-13 Campbell Elizabeth S Officer A-Award A Common Stock 20,613 0.00 35,920 D
2025-11-13 Battaglia Silvana Officer F-InKind D Common Stock 5,612 312.53 1.75M 19,947 D
2025-11-12 Verma Pawan Officer A-Award A Restricted Stock Units 3,963 0.00 3,963 D
2025-11-12 Mauch Robert P. Director / Officer A-Award A Restricted Stock Units 15,960 0.00 15,960 D
2025-11-12 Krikorian Lazarus Officer A-Award A Restricted Stock Units 2,271 0.00 2,271 D
2025-11-12 Cleary James F Officer A-Award A Restricted Stock Units 4,733 0.00 4,733 D
2025-11-12 Campbell Elizabeth S Officer A-Award A Restricted Stock Units 3,523 0.00 3,523 D
2025-11-12 Battaglia Silvana Officer A-Award A Restricted Stock Units 2,202 0.00 2,202 D
2025-11-07 Mauch Robert P. Director / Officer M-Exempt A Common Stock 4,065 0.00 44,485 D
2025-11-07 Krikorian Lazarus Officer M-Exempt D Restricted Stock Units 1,398 0.00 1,398 D
2025-11-07 Cleary James F Officer M-Exempt A Common Stock 2,951 0.00 117,244 D
2025-11-07 Campbell Elizabeth S Officer M-Exempt D Restricted Stock Units 2,023 0.00 0 D
2025-11-07 Battaglia Silvana Officer F-InKind D Common Stock 473 360.70 170.6K 12,674 D
2025-11-01 Tyler Lauren M Director A-Award A Common Stock 89 337.81 30.1K 3,069 D
2025-11-01 NALLY DENNIS M Director A-Award A Common Stock 104 337.81 35.1K 13,477 D
2025-11-01 Baumann Werner Director A-Award A Common Stock 108 337.81 36.5K 3,130 D
2025-10-31 Verma Pawan Officer M-Exempt D Restricted Stock Units 8,537 0.00 0 D
2025-10-20 Mauch Robert P. Director / Officer M-Exempt A Common Stock 3,763 86.09 324.0K 43,037 D
2025-10-01 Verma Pawan Officer Common Stock 0 0.00 14 D
2025-10-01 Campbell Elizabeth S Officer S-Sale D Common Stock 1,886 313.28 590.8K 12,824 D
2025-09-30 Clyburn Frank Director Common Stock 0 0.00 1,167 D
2025-09-18 Mauch Robert P. Director / Officer M-Exempt A Common Stock 3,763 86.09 324.0K 44,371 D
2025-09-16 COLLIS STEVEN H Director / Officer M-Exempt A Common Stock 29,350 86.09 2.53M 337,263 D
2025-08-19 COLLIS STEVEN H Director / Officer S-Sale D Common Stock 14,579 289.98 4.23M 307,913 D
2025-08-18 Mauch Robert P. Director / Officer M-Exempt A Common Stock 3,225 86.09 277.6K 45,576 D
2025-08-01 Tyler Lauren M Director A-Award A Common Stock 105 288.35 30.3K 2,980 D
2025-08-01 NALLY DENNIS M Director A-Award A Common Stock 122 288.35 35.2K 13,373 D
2025-08-01 Baumann Werner Director A-Award A Common Stock 126 288.35 36.3K 3,022 D
2025-07-22 COLLIS STEVEN H Director / Officer M-Exempt A Common Stock 12,578 86.09 1.08M 324,491 D
2025-07-18 Mauch Robert P. Director / Officer M-Exempt A Common Stock 3,225 86.09 277.6K 47,319 D
2025-07-01 Ryerkerk Lori Director A-Award A Common Stock 516 0.00 516 D
2025-06-30 Campbell Elizabeth S Officer A-Award A Common Stock 46 254.87 11.6K 14,710 D
2025-06-30 Battaglia Silvana Officer A-Award A Common Stock 53 254.87 13.4K 11,349 D
2025-06-24 COLLIS STEVEN H Director / Officer M-Exempt A Common Stock 12,579 86.09 1.08M 326,492 D
2025-06-18 Mauch Robert P. Director / Officer M-Exempt A Common Stock 3,225 86.09 277.6K 49,063 D
2025-06-18 Battaglia Silvana Officer S-Sale D Common Stock 4,077 297.41 1.21M 11,297 D
2025-06-01 Ryerkerk Lori Director 0 0.00 0
2025-05-29 Krikorian Lazarus Officer S-Sale D Common Stock 2,992 288.96 864.6K 17,162 D
2025-05-20 COLLIS STEVEN H Director / Officer M-Exempt A Common Stock 12,578 86.09 1.08M 328,491 D
2025-05-19 Mauch Robert P. Director / Officer S-Sale D Common Stock 4,969 291.43 1.45M 45,838 D
2025-05-14 GREENBERG LON R Director S-Sale D Common Stock 3,000 279.05 837.2K 17,851 D
2025-05-01 Tyler Lauren M Director A-Award A Common Stock 104 290.43 30.2K 2,875 D
2025-05-01 NALLY DENNIS M Director A-Award A Common Stock 121 290.43 35.1K 13,251 D
2025-05-01 Baumann Werner Director A-Award A Common Stock 125 290.43 36.3K 2,896 D
2025-04-23 Cleary James F Officer J-Other D Common Stock 35,000 0.00 114,293 D
2025-04-22 COLLIS STEVEN H Director / Officer M-Exempt A Common Stock 12,579 86.09 1.08M 330,492 D
2025-04-21 Mauch Robert P. Director / Officer S-Sale D Common Stock 4,969 289.33 1.44M 47,582 D
2025-03-25 COLLIS STEVEN H Director / Officer S-Sale D Common Stock 12,578 269.51 3.39M 319,913 D
2025-03-24 Campbell Elizabeth S Officer S-Sale D Common Stock 2,000 268.28 536.6K 14,665 D
2025-03-18 Mauch Robert P. Director / Officer M-Exempt A Common Stock 3,226 86.09 277.7K 54,296 D
2025-03-10 Krikorian Lazarus Officer S-Sale D Common Stock 2,000 260.06 520.1K 20,154 D
2025-03-06 Tyler Lauren M Director A-Award A Common Stock 789 0.00 2,771 D
2025-03-06 NALLY DENNIS M Director A-Award A Common Stock 789 0.00 13,130 D
2025-03-06 Miller Redonda Director A-Award A Common Stock 789 0.00 3,194 D
2025-03-06 Kim Lorence H. Director A-Award A Common Stock 789 0.00 3,524 D
2025-03-06 GREENBERG LON R Director A-Award A Common Stock 789 0.00 20,851 D
2025-03-06 DURCAN DERMOT MARK Director A-Award A Common Stock 986 0.00 22,862 D
2025-03-06 Clyburn Frank Director A-Award A Common Stock 789 0.00 1,157 D
2025-03-06 Baumann Werner Director A-Award A Common Stock 789 0.00 2,771 D
2025-03-03 Mauch Robert P. Director / Officer M-Exempt A Common Stock 3,226 86.09 277.7K 54,296 D
2025-02-27 COLLIS STEVEN H Director / Officer M-Exempt A Common Stock 12,579 86.09 1.08M 332,492 D
2025-02-21 Battaglia Silvana Officer S-Sale D Common Stock 5,000 242.24 1.21M 15,374 D
2025-02-06 Walgreens Boots Alliance, Inc. 10% Owner J-Other D Common Stock 447,775 244.51 109.49M 12,774,491 I
2025-01-31 Tyler Lauren M Director A-Award A Common Stock 99 254.21 25.2K 1,982 D
2025-01-31 NALLY DENNIS M Director A-Award A Common Stock 123 254.21 31.3K 12,341 D
2025-01-31 Baumann Werner Director A-Award A Common Stock 99 254.21 25.2K 1,982 D
2025-01-03 Krikorian Lazarus Officer M-Exempt A Common Stock 252 0.00 22,240 D
2024-12-31 Campbell Elizabeth S Officer A-Award A Common Stock 53 190.98 10.2K 18,792 D
2024-12-31 Battaglia Silvana Officer A-Award A Common Stock 45 190.98 8.6K 20,374 D
2024-12-20 Battaglia Silvana Officer S-Sale D Common Stock 1,678 228.72 383.8K 20,329 D
2024-12-18 Mauch Robert P. Director / Officer F-InKind D Common Stock 789 232.24 183.2K 52,814 D
2024-12-18 Krikorian Lazarus Officer M-Exempt A Common Stock 108 0.00 22,096 D
2024-12-18 Cleary James F Officer M-Exempt D Restricted Stock Units 207 0.00 6,043 D
2024-12-18 COLLIS STEVEN H Director / Officer M-Exempt D Restricted Stock Units 395 0.00 9,474 D
2024-12-03 Krikorian Lazarus Officer S-Sale D Common Stock 1,816 250.42 454.8K 21,988 D
2024-11-27 Cleary James F Officer M-Exempt A Common Stock 33,877 89.58 3.03M 171,508 D
2024-11-25 COLLIS STEVEN H Director / Officer S-Sale D Common Stock 50,000 243.98 12.20M 326,557 D
2024-11-21 Mauch Robert P. Director / Officer F-InKind D Common Stock 16,715 225.08 3.76M 52,814 D
2024-11-21 Krikorian Lazarus Officer F-InKind D Common Stock 792 225.08 178.3K 23,804 D
2024-11-21 Cleary James F Officer F-InKind D Common Stock 16,248 225.08 3.66M 137,631 D
2024-11-21 Campbell Elizabeth S Officer F-InKind D Common Stock 6,094 225.08 1.37M 18,738 D
2024-11-21 COLLIS STEVEN H Director / Officer A-Award A Common Stock 123,528 0.00 430,280 D
2024-11-21 Battaglia Silvana Officer F-InKind D Common Stock 6,218 225.08 1.40M 22,007 D
2024-11-20 Mauch Robert P. Director / Officer A-Award A Restricted Stock Units 19,737 0.00 19,737 D
2024-11-20 Krikorian Lazarus Officer A-Award A Restricted Stock Units 3,393 0.00 3,393 D
2024-11-20 Cleary James F Officer A-Award A Restricted Stock Units 6,250 0.00 6,250 D
2024-11-20 Campbell Elizabeth S Officer A-Award A Restricted Stock Units 4,770 0.00 4,770 D
2024-11-20 COLLIS STEVEN H Director / Officer A-Award A Restricted Stock Units 9,869 0.00 9,869 D
2024-11-20 Battaglia Silvana Officer A-Award A Restricted Stock Units 2,797 0.00 2,797 D
2024-11-19 COLLIS STEVEN H Director / Officer S-Sale D Common Stock 21,509 242.16 5.21M 306,752 D
2024-11-08 Mauch Robert P. Director / Officer M-Exempt A Common Stock 4,215 0.00 30,725 D
2024-11-08 Krikorian Lazarus Officer M-Exempt A Common Stock 1,061 0.00 21,103 D
2024-11-08 Cleary James F Officer M-Exempt D Restricted Stock Units 3,395 0.00 0 D
2024-11-08 Campbell Elizabeth S Officer M-Exempt A Common Stock 2,023 0.00 11,030 D
2024-11-08 COLLIS STEVEN H Director / Officer F-InKind D Common Stock 3,067 248.41 761.9K 306,752 D
2024-11-08 Battaglia Silvana Officer M-Exempt A Common Stock 1,084 0.00 14,422 D
2024-11-01 Tyler Lauren M Director A-Award A Common Stock 107 234.27 25.1K 1,883 D
2024-11-01 NALLY DENNIS M Director A-Award A Common Stock 134 234.27 31.4K 12,218 D
2024-11-01 Clyburn Frank Director A-Award A Common Stock 368 234.27 86.2K 368 D
2024-11-01 Baumann Werner Director A-Award A Common Stock 107 234.27 25.1K 1,883 D
2024-10-22 COLLIS STEVEN H Director / Officer M-Exempt A Common Stock 21,509 89.58 1.93M 306,597 D
2024-10-01 Clyburn Frank Director 0 0.00 0
2024-09-17 COLLIS STEVEN H Director / Officer S-Sale D Common Stock 21,509 241.01 5.18M 285,088
2024-08-20 COLLIS STEVEN H Director / Officer M-Exempt D Non-qualified Stock Option (Right to Buy) 10,754 89.58 963.3K 64,527
2024-08-06 Battaglia Silvana Officer S-Sale D Common Stock 1,473 242.69 357.5K 10,948
2024-08-05 GREENBERG LON R Director G-Gift D Common Stock 5,000 0.00 20,062
2024-08-01 Walgreens Boots Alliance, Inc. 10% Owner S-Sale D Common Stock 4,438,171 240.56 1.07B 19,980,000
2024-08-01 Tyler Lauren M Director A-Award A Common Stock 103 244.46 25.2K 1,776
2024-08-01 NALLY DENNIS M Director A-Award A Common Stock 128 244.46 31.3K 12,084
2024-08-01 Baumann Werner Director A-Award A Common Stock 103 244.46 25.2K 1,776
2024-07-16 COLLIS STEVEN H Director / Officer M-Exempt D Non-qualified Stock Option (Right to Buy) 10,755 89.58 963.4K 75,281
2024-07-01 Donato Leslie E Officer M-Exempt A Common Stock 1,432 0.00 9,991
2024-06-28 Donato Leslie E Officer A-Award A Common Stock 67 191.51 12.8K 9,525
2024-06-28 Campbell Elizabeth S Officer A-Award A Common Stock 58 191.51 11.1K 8,304
2024-06-28 Battaglia Silvana Officer A-Award A Common Stock 66 191.51 12.7K 12,421
2024-06-18 COLLIS STEVEN H Director / Officer M-Exempt D Non-qualified Stock Option (Right to Buy) 10,754 89.58 963.3K 86,036
2024-05-31 Clark Gina Officer S-Sale D Common Stock 1,874 223.86 419.5K 13,284
2024-05-29 Clark Gina Officer S-Sale D Common Stock 27,093 216.07 5.85M 15,158
2024-05-24 DURCAN DERMOT MARK Director P-Purchase A Common Stock 500 218.58 109.3K 21,876
2024-05-22 Walgreens Boots Alliance, Inc. 10% Owner S-Sale D Common Stock 1,859,390 215.12 400.00M 24,418,171
2024-05-21 COLLIS STEVEN H Director / Officer S-Sale D Common Stock 10,755 221.30 2.38M 285,088
2024-05-01 Tyler Lauren M Director A-Award A Common Stock 110 229.20 25.2K 1,673
2024-05-01 NALLY DENNIS M Director A-Award A Common Stock 137 229.20 31.4K 11,956
2024-05-01 Baumann Werner Director A-Award A Common Stock 110 229.20 25.2K 1,673
2024-04-16 COLLIS STEVEN H Director / Officer M-Exempt D Non-qualified Stock Option (Right to Buy) 10,754 89.58 963.3K 107,545
2024-04-15 Mauch Robert P. Officer M-Exempt A Common Stock 33,877 89.58 3.03M 81,976
2024-03-19 COLLIS STEVEN H Director / Officer M-Exempt A Common Stock 10,755 89.58 963.4K 295,843
2024-03-18 Clark Gina Officer S-Sale D Common Stock 9,644 238.12 2.30M 15,158
2024-03-18 Campbell Elizabeth S Officer S-Sale D Common Stock 6,977 238.12 1.66M 8,246
2024-03-12 Tyler Lauren M Director A-Award A Common Stock 843 0.00 1,563
2024-03-12 NALLY DENNIS M Director A-Award A Common Stock 843 0.00 11,819
2024-03-12 Miller Redonda Director A-Award A Common Stock 843 0.00 2,405
2024-03-12 Kim Lorence H. Director A-Award A Common Stock 843 0.00 2,735
2024-03-12 HYLE KATHLEEN W Director A-Award A Common Stock 843 0.00 24,406
2024-03-12 GREENBERG LON R Director A-Award A Common Stock 843 0.00 27,062
2024-03-12 GOCHNAUER RICHARD W Director A-Award A Common Stock 843 0.00 28,762
2024-03-12 DURCAN DERMOT MARK Director A-Award A Common Stock 1,053 0.00 21,376
2024-03-12 Baumann Werner Director A-Award A Common Stock 843 0.00 1,563
2024-03-11 NALLY DENNIS M Director M-Exempt D Restricted Stock Units 1,593 0.00 0
2024-03-11 HYLE KATHLEEN W Director M-Exempt D Restricted Stock Units 1,593 0.00 0
2024-03-11 GOCHNAUER RICHARD W Director M-Exempt D Restricted Stock Units 1,593 0.00 0
2024-03-11 DURCAN DERMOT MARK Director M-Exempt D Restricted Stock Units 1,593 0.00 0
2024-03-11 Cleary James F Officer A-Award A Restricted Stock Units 12,623 0.00 12,623
2024-03-11 Campbell Elizabeth S Officer A-Award A Restricted Stock Units 12,623 0.00 12,623
2024-03-11 Battaglia Silvana Officer A-Award A Restricted Stock Units 8,415 0.00 8,415
2024-03-08 Battaglia Silvana Officer M-Exempt D Restricted Stock Units 1,211 0.00 0
2024-02-13 Clark Gina Officer S-Sale D Common Stock 1,100 230.48 253.5K 24,802
2024-02-07 Walgreens Boots Alliance, Inc. 10% Owner S-Sale D Common Stock 4,212,395 235.41 991.64M 26,277,561
2024-02-01 Tyler Lauren M Director A-Award A Common Stock 106 0.00 720
2024-02-01 NALLY DENNIS M Director A-Award A Common Stock 132 236.92 31.3K 9,383
2024-02-01 Baumann Werner Director A-Award A Common Stock 106 0.00 720
2024-01-15 GREENBERG LON R Director M-Exempt A Common Stock 1,340 219.43 294.0K 26,219
2024-01-04 Donato Leslie E Officer A-Award A Common Stock 40 174.57 7.0K 8,559
2024-01-04 Campbell Elizabeth S Officer A-Award A Common Stock 58 174.57 10.0K 15,223

Executive team

Top executives
EBIT / Employee
57.0K
Shares Outstanding
194.53M

Executive compensation

Executive compensation (annual)
# Year Executive Salary Bonus Stock award Option award Incentive Other Total % Stock-
based
Filing
1 2025 Robert P. Mauch President and Chief Executive Officer 1.35M 12.00M 4.28M 622.8K 18.26M 65.73%
2 2025 Steven H. Collis Executive Chairman 1.00M 6.00M 1.81M 867.0K 9.68M 61.98%
3 2025 James F. Cleary Executive Vice President and Chief Financial Officer 926.1K 3.80M 1.68M 116.5K 6.52M 58.27%
4 2025 Elizabeth S. Campbell Executive Vice President and Chief Legal Officer 769.2K 2.90M 1.39M 112.7K 5.18M 56.02%
5 2025 Silvana Battaglia Executive Vice President and Chief Human Resources Officer 664.8K 1.70M 1.21M 92.7K 3.66M 46.42%
6 2024 Steven H. Collis Executive Chairman 1.46M 12.50M 4.10M 408.2K 18.48M 67.66%
7 2024 Steven H. Collis Chairman, President and Chief Executive Officer 1.46M 12.50M 4.10M 408.2K 18.48M 67.66%
8 2024 Robert P. Mauch President and Chief Executive Officer 1.04M 6.00M 2.08M 133.2K 9.25M 64.84%
9 2024 Robert P. Mauch Executive Vice President and Chief Operating Officer 1.04M 6.00M 2.08M 133.2K 9.25M 64.84%
10 2024 James F. Cleary Executive Vice President and Chief Financial Officer 885.9K 6.60M 1.42M 100.0K 9.00M 73.31%
11 2024 Elizabeth S. Campbell Executive Vice President and Chief Legal Officer 722.0K 5.70M 1.16M 91.4K 7.67M 74.33%
12 2024 Silvana Battaglia Executive Vice President and Chief Human Resources Officer 626.0K 3.60M 1.00M 92.3K 5.32M 67.67%
13 2023 Steven H. Collis Chairman, President and Chief Executive Officer 1.40M 12.50M 3.23M 379.5K 17.51M 71.38%
14 2023 Steven H. Collis Executive Chairman 1.40M 12.50M 3.23M 379.5K 17.51M 71.38%
15 2023 Robert P. Mauch Executive Vice President and Chief Operating Officer 975.0K 5.00M 1.61M 115.1K 7.70M 64.96%
16 2023 Robert P. Mauch President and Chief Executive Officer 975.0K 5.00M 1.61M 115.1K 7.70M 64.96%
17 2023 James F. Cleary Executive Vice President and Chief Financial Officer 795.0K 3.50M 1.05M 105.5K 5.45M 64.23%
18 2023 Elizabeth S. Campbell Executive Vice President and Chief Legal Officer 670.0K 2.40M 883.7K 73.4K 4.03M 59.60%
19 2023 Gina K. Clark Executive Vice President and Chief Communications & Administration Officer 640.0K 1.60M 844.2K 85.9K 3.17M 50.47%
20 2023 Silvana Battaglia Executive Vice President and Chief Human Resources Officer 600.0K 1.50M 791.4K 84.8K 2.98M 50.40%
21 2022 Steven H. Collis Chairman, President and Chief Executive Officer 1.40M 11.25M 3.22M 870.3K 16.74M 67.22%
22 2022 Robert P. Mauch Executive Vice President and Chief Operating Officer 850.0K 3.50M 1.18M 285.4K 5.82M 60.15%
23 2022 James F. Cleary Executive Vice President and Chief Financial Officer 770.0K 3.20M 1.07M 279.9K 5.32M 60.13%
24 2022 Silvana Battaglia Executive Vice President and Chief Human Resources Officer 580.0K 1.90M 807.3K 192.3K 3.48M 54.61%
25 2022 Gina K. Clark Executive Vice President and Chief Communications & Administration Officer 620.0K 1.50M 863.0K 193.9K 3.18M 47.22%
26 2021 Steven H. Collis Chairman, President and Chief Executive Officer 1.40M 10.50M 2.25M 724.5K 14.87M 70.60%
27 2021 Robert P. Mauch Executive Vice President and Chief Operating Officer 800.0K 3.30M 1.27M 233.4K 5.61M 58.85%
28 2021 Robert P. Mauch Executive Vice President and Group President 800.0K 3.30M 1.27M 233.4K 5.61M 58.85%
29 2021 James F. Cleary Executive Vice President and Chief Financial Officer 750.0K 3.00M 1.19M 224.1K 5.17M 58.04%
30 2021 John G. Chou Executive Vice President and Special Advisor to the Chairman & CEO (formerly the Chief Legal Officer) 690.0K 2.40M 1.10M 224.8K 4.41M 54.37%
31 2021 Gina K. Clark Executive Vice President and Chief Communications & Administration Officer 600.0K 1.50M 955.9K 161.4K 3.22M 46.62%
32 2020 Steven H. Collis Chairman, President and Chief Executive Officer 1.33M 6.83M 2.93M 2.53M 692.1K 14.30M 68.21%
33 2020 Paul E. Szurek President and Chief Executive Officer 675.0K 4.33M 830.2K 20.8K 5.86M 73.95%
34 2020 Robert P. Mauch Executive Vice President and Chief Operating Officer 700.0K 1.75M 750.0K 890.4K 219.2K 4.31M 58.01%
35 2020 Robert P. Mauch Executive Vice President and Group President 700.0K 1.75M 750.0K 890.4K 219.2K 4.31M 58.01%
36 2020 James F. Cleary Executive Vice President and Chief Financial Officer 700.0K 1.75M 750.0K 890.4K 192.5K 4.28M 58.37%
37 2020 John G. Chou Executive Vice President and Special Advisor to the Chairman & CEO (formerly the Chief Legal Officer) 675.0K 1.61M 690.0K 858.6K 215.1K 4.05M 56.81%
38 2020 John G. Chou Executive Vice President and Chief Legal Officer 675.0K 1.61M 690.0K 858.6K 215.1K 4.05M 56.81%
39 2020 Gina K. Clark Executive Vice President and Chief Communications & Administration Officer 575.0K 1.05M 450.0K 731.4K 149.2K 2.96M 50.75%
40 2020 Steven J. Smith Chief Revenue Officer 436.2K 1.27M 482.8K 15.5K 2.20M 57.61%
41 2020 Jeffrey S. Finnin Chief Financial Officer 477.7K 1.06M 352.5K 19.2K 1.91M 55.48%
42 2020 Derek S. McCandless Senior Vice President, Legal, General Counsel and Secretary 391.0K 719.7K 312.2K 14.5K 1.44M 50.07%
43 2020 Brian P. Warren Senior Vice President, Development and Product Engineering 340.1K 741.0K 202.3K 14.7K 1.30M 57.08%
44 2019 Steven H. Collis Chairman, President and Chief Executive Officer 1.24M 5.60M 2.40M 1.87M 202.9K 11.31M 70.74%
45 2019 Steven H. Collis Chairman, President and CEO 1.24M 5.60M 2.40M 1.87M 202.9K 11.31M 70.74%
46 2019 Paul E. Szurek President and Chief Executive Officer 650.0K 4.26M 460.4K 17.5K 5.39M 79.05%
47 2019 Robert P. Mauch Executive Vice President and Group President 675.0K 1.47M 630.1K 677.4K 85.1K 3.54M 59.37%
48 2019 John G. Chou Executive Vice President, Chief Legal Officer and Secretary 660.0K 1.47M 630.1K 662.3K 86.2K 3.51M 59.86%
49 2019 John G. Chou Executive Vice President and Chief Legal Officer 660.0K 1.47M 630.1K 662.3K 86.2K 3.51M 59.86%
50 2019 John G. Chou Executive Vice President and Special Advisor to the Chairman & CEO (formerly the Chief Legal Officer) 660.0K 1.47M 630.1K 662.3K 86.2K 3.51M 59.86%
51 2019 James F. Cleary Executive Vice President and CFO 638.8K 1.47M 630.1K 652.3K 62.3K 3.45M 60.81%
52 2019 James F. Cleary Executive Vice President and Chief Financial Officer 638.8K 1.47M 630.1K 652.3K 62.3K 3.45M 60.81%
53 2019 Gina K. Clark Executive Vice President and Chief Communications & Administration Officer 500.0K 910.0K 390.1K 501.8K 64.4K 2.37M 54.94%
54 2019 Steven J. Smith Chief Revenue Officer 411.3K 1.25M 267.8K 14.1K 1.94M 64.24%
55 2019 Jeffrey S. Finnin Chief Financial Officer 455.0K 1.04M 195.5K 18.6K 1.71M 60.80%
56 2019 Tim G. Guttman Former Executive Vice President and CFO 710.0K 657.5K 1.37M 0.00%
57 2019 Derek S. McCandless Senior Vice President, Legal, General Counsel and Secretary 362.0K 674.5K 155.6K 16.2K 1.21M 55.82%
58 2019 Brian P. Warren Senior Vice President, Development and Product Engineering 312.5K 700.5K 108.8K 14.1K 1.14M 61.67%
59 2018 Steven H. Collis Chairman, President and Chief Executive Officer 1.24M 5.60M 2.40M 2.05M 223.4K 11.51M 69.48%
60 2018 Steven H. Collis Chairman, President and Executive Officer Chief 1.24M 5.60M 2.40M 2.05M 223.4K 11.51M 69.48%
61 2018 Steven H. Collis Chairman, President and CEO 1.24M 5.60M 2.40M 2.05M 223.4K 11.51M 69.48%
62 2018 Paul E. Szurek President and Chief Executive Officer 632.5K 4.18M 875.9K 14.7K 5.71M 73.31%
63 2018 Tim G. Guttman Executive Vice President and Chief Financial Officer 710.0K 1.75M 750.0K 782.8K 92.9K 4.09M 61.19%
64 2018 Tim G. Guttman Former Executive Vice President and CFO 710.0K 1.75M 750.0K 782.8K 92.9K 4.09M 61.19%
65 2018 John G. Chou Executive Vice President, Chief Legal Officer and Secretary 660.0K 1.47M 630.0K 727.7K 82.9K 3.57M 58.81%
66 2018 John G. Chou Executive Vice President and Chief Legal Officer 660.0K 1.47M 630.0K 727.7K 82.9K 3.57M 58.81%
67 2018 John G. Chou Executive Vice President and Chief Legal & Business Officer 660.0K 1.47M 630.0K 727.7K 82.9K 3.57M 58.81%
68 2018 Robert P. Mauch Executive Vice President and Group President 675.0K 1.47M 630.0K 563.4K 67.3K 3.41M 61.66%
69 2018 Robert P. Mauch Executive Vice President and Group President, Pharmaceutical Distribution & Strategic Global 675.0K 1.47M 630.0K 563.4K 67.3K 3.41M 61.66%
70 2018 James F. Cleary Executive Vice President and CFO 575.0K 1.26M 540.0K 485.6K 246.6K 3.11M 57.93%
71 2018 James F. Cleary Executive Vice President and Chief Financial Officer 575.0K 1.26M 540.0K 485.6K 246.6K 3.11M 57.93%
72 2018 James F. Cleary, Jr. Executive Vice President and President, Global Commercialization Services & Animal Health 575.0K 1.26M 540.0K 485.6K 246.6K 3.11M 57.93%
73 2018 Steven J. Smith Chief Revenue Officer 380.0K 933.8K 466.9K 13.9K 1.79M 52.03%
74 2018 Jeffrey S. Finnin Chief Financial Officer 431.6K 959.7K 355.7K 11.9K 1.76M 54.56%
75 2018 Derek S. McCandless Senior Vice President, Legal, General Counsel and Secretary 346.3K 622.5K 283.0K 14.2K 1.27M 49.17%
76 2018 Brian P. Warren Senior Vice President, Development and Product Engineering 285.1K 555.1K 187.6K 10.6K 1.04M 53.46%
77 2017 Steven H. Collis Chairman, President and CEO 1.24M 4.20M 2.80M 1.34M 327.4K 9.91M 70.65%
78 2017 Steven H. Collis Chairman, President and Executive Officer Chief 1.24M 4.20M 2.80M 1.34M 327.4K 9.91M 70.65%
79 2017 Paul E. Szurek President and Chief Executive Officer 580.0K 2.62M 843.2K 36.7K 4.08M 64.24%
80 2017 Tim G. Guttman Former Executive Vice President and CFO 710.0K 1.50M 1.00M 511.5K 121.5K 3.84M 65.05%
81 2017 Tim G. Guttman Executive Vice President and Chief Financial Officer 710.0K 1.50M 1.00M 511.5K 121.5K 3.84M 65.05%
82 2017 John G. Chou Executive Vice President and Chief Legal & Business Officer 633.0K 1.20M 800.0K 456.9K 94.4K 3.18M 62.81%
83 2017 John G. Chou Executive Vice President, Chief Legal Officer and Secretary 633.0K 1.20M 800.0K 456.9K 94.4K 3.18M 62.81%
84 2017 James D. Frary Former Executive Vice President and President, AmerisourceBergen Specialty Group 600.0K 1.08M 720.0K 631.6K 112.4K 3.14M 57.25%
85 2017 Robert P. Mauch Executive Vice President and Group President, Pharmaceutical Distribution & Strategic Global 618.8K 1.20M 800.0K 217.5K 109.6K 2.95M 67.89%
86 2017 Robert P. Mauch Executive Vice President and Group President, Pharmaceutical Distribution & Strategic Global Sourcing 618.8K 1.20M 800.0K 217.5K 109.6K 2.95M 67.89%
87 2017 Robert P. Mauch Executive Vice President and Group President 618.8K 1.20M 800.0K 217.5K 109.6K 2.95M 67.89%
88 2017 Peyton R. Howell Executive Vice President and President, Health Systems & Specialty Care Solutions 533.8K 900.0K 600.0K 385.9K 96.4K 2.52M 59.62%
89 2017 Steven J. Smith Chief Revenue Officer 356.9K 839.3K 477.6K 10.6K 1.68M 49.83%
90 2017 Steven J. Smith Senior Vice President, Sales and Marketing 356.9K 839.3K 477.6K 10.6K 1.68M 49.83%
91 2017 Jeffrey S. Finnin Chief Financial Officer 413.3K 891.8K 366.4K 11.9K 1.68M 52.98%
92 2017 Derek S. McCandless Senior Vice President, Legal, General Counsel and Secretary 329.6K 577.0K 268.1K 10.6K 1.19M 48.68%
93 2017 Brian P. Warren Senior Vice President, Engineering and Product 268.3K 524.6K 176.1K 10.5K 979.4K 53.56%
94 2017 Brian P. Warren Senior Vice President, Development and Product Engineering 268.3K 524.6K 176.1K 10.5K 979.4K 53.56%
95 2016 Steven H. Collis Chairman, President and Executive Officer Chief 1.23M 4.02M 2.68M 1.33M 713.2K 9.98M 67.15%
96 2016 Paul E. Szurek President and Chief Executive Officer 246.1K 250.0K 3.32M 242.7K 56.4K 4.12M 80.69%
97 2016 Thomas M. Ray Former President and Chief Executive Officer 402.4K 2.41M 514.6K 143.7K 3.47M 69.43%
98 2016 Tim G. Guttman Executive Vice President and Chief Financial Officer 706.5K 1.20M 800.0K 508.0K 153.9K 3.37M 59.37%
99 2016 John G. Chou Executive Vice President and General Counsel 621.2K 1.20M 800.0K 446.5K 123.1K 3.19M 62.68%
100 2016 John G. Chou Executive Vice President and Chief Legal & Business Officer 621.2K 1.20M 800.0K 446.5K 123.1K 3.19M 62.68%
101 2016 James D. Frary Former Executive Vice President and President, AmerisourceBergen Specialty Group 597.7K 960.0K 640.0K 760.0K 130.7K 3.09M 51.81%
102 2016 James D. Frary Executive Vice President and President, AmerisourceBergen Specialty Group 597.7K 960.0K 640.0K 760.0K 130.7K 3.09M 51.81%
103 2016 Robert P. Mauch Executive Vice President and Group President, Pharmaceutical Distribution & Strategic Global Sourcing 593.1K 1.08M 720.0K 307.1K 74.6K 2.77M 64.87%
104 2016 Robert P. Mauch Executive Vice President and Group President, Pharmaceutical Distribution & Strategic Global 593.1K 1.08M 720.0K 307.1K 74.6K 2.77M 64.87%
105 2016 Robert P. Mauch Executive Vice President and President, AmerisourceBergen Drug Corporation 593.1K 1.08M 720.0K 307.1K 74.6K 2.77M 64.87%
106 2016 Steven J. Smith Senior Vice President, Sales and Marketing 329.6K 821.2K 629.5K 10.6K 1.79M 45.85%
107 2016 Steven J. Smith Chief Revenue Officer 329.6K 821.2K 629.5K 10.6K 1.79M 45.85%
108 2016 Jeffrey S. Finnin Chief Financial Officer 392.3K 657.0K 367.4K 11.9K 1.43M 45.99%
109 2016 Derek S. McCandless Senior Vice President, Legal, General Counsel and Secretary 309.6K 547.5K 320.6K 10.6K 1.12M 48.96%
110 2016 Brian P. Warren Senior Vice President, Development and Product Engineering 244.6K 438.0K 214.7K 10.0K 907.3K 48.27%
111 2016 Brian P. Warren Senior Vice President, Engineering and Product 244.6K 438.0K 214.7K 10.0K 907.3K 48.27%
112 2015 Steven H. Collis Chairman, President and Executive Officer Chief 1.19M 4.02M 2.68M 2.45M 463.5K 10.80M 62.03%
113 2015 Steven H. Collis President and Chief Executive Officer 1.19M 4.02M 2.68M 2.45M 463.5K 10.80M 62.03%
114 2015 Thomas M. Ray President and Chief Executive Officer 543.3K 2.43M 877.3K 11.9K 3.86M 62.89%
115 2015 Thomas M. Ray Former President and Chief Executive Officer 543.3K 2.43M 877.3K 11.9K 3.86M 62.89%
116 2015 Tim G. Guttman Executive Vice President and Chief Financial Officer 676.5K 1.20M 800.0K 1.04M 133.2K 3.85M 52.01%
117 2015 David W. Neu Executive Vice President and President, Good Neighbor 630.0K 1.02M 683.2K 802.8K 287.1K 3.43M 49.83%
118 2015 James D. Frary Former Executive Vice President and President, AmerisourceBergen Specialty Group 574.2K 900.1K 600.0K 972.7K 104.6K 3.15M 47.60%
119 2015 James D. Frary Executive Vice President and President, AmerisourceBergen Specialty Group 574.2K 900.1K 600.0K 972.7K 104.6K 3.15M 47.60%
120 2015 John G. Chou Executive Vice President and General Counsel 600.0K 780.0K 520.0K 914.0K 113.8K 2.93M 44.40%
121 2015 John G. Chou Executive Vice President and Chief Legal & Business Officer 600.0K 780.0K 520.0K 914.0K 113.8K 2.93M 44.40%
122 2015 Steven J. Smith Senior Vice President, Sales and Marketing 311.0K 551.7K 685.0K 10.5K 1.56M 35.41%
123 2015 Jeffrey S. Finnin Chief Financial Officer 382.3K 662.1K 250.0K 11.9K 1.31M 50.68%
124 2015 Derek S. McCandless Senior Vice President, Legal, General Counsel and Secretary 291.6K 551.7K 250.0K 10.4K 1.10M 49.98%
125 2015 Brian P. Warren Senior Vice President, Engineering and Product 226.0K 331.1K 220.0K 9.3K 786.4K 42.10%
126 2014 Steven H. Collis President and Chief Executive Officer 1.19M 4.02M 2.68M 1.86M 157.3K 9.90M 67.66%
127 2014 Steven H. Collis President and Chief Executive Officer 1.19M 4.02M 2.68M 1.86M 157.3K 9.90M 67.66%
128 2014 Steven H. Collis Chairman, President and Executive Officer Chief 1.19M 4.02M 2.68M 1.86M 157.3K 9.90M 67.66%
129 2014 David W. Neu Executive Vice President and President, Good Neighbor 626.5K 1.02M 680.0K 767.7K 327.4K 3.42M 49.68%
130 2014 David W. Neu Executive Vice President and President, AmerisourceBergen 626.5K 1.02M 680.0K 767.7K 69.3K 3.42M 49.68%
131 2014 Thomas M. Ray Former President and Chief Executive Officer 510.0K 2.04M 693.0K 11.7K 3.25M 62.66%
132 2014 Thomas M. Ray President and Chief Executive Officer 510.0K 2.04M 693.0K 11.7K 3.25M 62.66%
133 2014 Tim G. Guttman Executive Vice President and Chief Financial Officer 632.7K 1.02M 680.0K 752.4K 56.0K 3.14M 54.12%
134 2014 Tim G. Guttman Executive Vice President and Chief Financial Officer 632.7K 1.02M 680.0K 752.4K 56.0K 3.14M 54.12%
135 2014 James D. Frary Executive Vice President and President, AmerisourceBergen Specialty Group 515.0K 780.0K 520.0K 581.6K 52.7K 2.45M 53.07%
136 2014 James D. Frary Executive Vice President and President, AmerisourceBergen 515.0K 780.0K 520.0K 581.6K 52.7K 2.45M 53.07%
137 2014 John G. Chou Executive Vice President and General Counsel 584.1K 660.0K 440.0K 694.6K 61.7K 2.44M 45.07%
138 2014 John G. Chou Executive Vice President and General Counsel 584.1K 660.0K 440.0K 694.6K 61.7K 2.44M 45.07%
139 2014 Steven J. Smith Senior Vice President, Sales and Marketing 276.9K 150.0K 577.9K 568.6K 6.0K 1.58M 36.59%
140 2014 Jeffrey S. Finnin Chief Financial Officer 372.5K 555.8K 250.0K 11.7K 1.19M 46.71%
141 2014 Derek S. McCandless Senior Vice President, Legal, General Counsel and Secretary 278.8K 463.2K 190.0K 10.4K 942.4K 49.15%
142 2013 Steven H. Collis President and Chief Executive Officer 1.16M 7.71M 1.68M 1.31M 144.0K 12.00M 78.22%
143 2013 Steven H. Collis President and Chief Executive Officer 1.16M 7.71M 1.68M 1.31M 144.0K 12.00M 78.22%
144 2013 David W. Neu Executive Vice President and President, AmerisourceBergen 600.0K 780.0K 520.0K 512.9K 61.7K 2.47M 52.53%
145 2013 David W. Neu Executive Vice President and President, Good Neighbor 600.0K 780.0K 520.0K 512.9K 61.7K 2.47M 52.53%
146 2013 David W. Neu Senior Vice President and President, AmerisourceBergen 600.0K 780.0K 520.0K 512.9K 61.7K 2.47M 52.53%
147 2013 Thomas M. Ray President and Chief Executive Officer 459.3K 900.0K 600.0K 400.0K 11.0K 2.37M 63.28%
148 2013 Tim G. Guttman Senior Vice President and 500.0K 720.0K 480.0K 437.9K 46.1K 2.18M 54.95%
149 2013 Tim G. Guttman Executive Vice President and Chief Financial Officer 500.0K 720.0K 480.0K 437.9K 46.1K 2.18M 54.95%
150 2013 Tim G. Guttman Executive Vice President and Chief Financial Officer 500.0K 720.0K 480.0K 437.9K 46.1K 2.18M 54.95%
151 2013 John G. Chou Executive Vice President and General Counsel 462.0K 540.0K 360.0K 395.4K 58.6K 1.82M 49.56%
152 2013 John G. Chou Executive Vice President and General Counsel 462.0K 540.0K 360.0K 395.4K 58.6K 1.82M 49.56%
153 2013 James D. Frary Senior Vice President and President, AmerisourceBergen 400.0K 540.0K 360.0K 300.1K 54.9K 1.65M 54.38%
154 2013 James D. Frary Executive Vice President and President, AmerisourceBergen Specialty Group 400.0K 540.0K 360.0K 300.1K 54.9K 1.65M 54.38%
155 2013 James D. Frary Executive Vice President and President, AmerisourceBergen 400.0K 540.0K 360.0K 300.1K 54.9K 1.65M 54.38%
156 2013 Jeffrey S. Finnin Chief Financial Officer 362.5K 330.0K 220.0K 216.8K 11.0K 1.14M 48.23%
157 2013 Derek S. McCandless Senior Vice President, Legal, General Counsel and Secretary 265.9K 288.0K 192.0K 146.5K 10.0K 902.4K 53.19%
158 2012 Steven H. Collis President and Chief Executive Officer 1.09M 2.70M 1.80M 1.35M 115.0K 7.06M 63.77%
159 2012 David W. Neu Executive Vice President and President, AmerisourceBergen 538.5K 510.0K 340.0K 441.3K 53.8K 2.14M 39.73%
160 2012 David W. Neu Senior Vice President and President, AmerisourceBergen 538.5K 510.0K 340.0K 441.3K 53.8K 2.14M 39.73%
161 2012 John G. Chou Executive Vice President and General Counsel 436.2K 465.0K 310.0K 449.4K 51.5K 1.71M 45.27%
162 2012 James D. Frary Senior Vice President and President, AmerisourceBergen 375.4K 375.0K 250.0K 492.5K 49.8K 1.54M 40.51%
163 2012 James D. Frary Executive Vice President and President, AmerisourceBergen 375.4K 375.0K 250.0K 492.5K 49.8K 1.54M 40.51%
164 2012 Tim G. Guttman Executive Vice President and Chief Financial Officer 363.2K 180.2K 334.8K 325.0K 23.8K 1.23M 41.97%
165 2012 Tim G. Guttman Senior Vice President and 363.2K 180.2K 334.8K 325.0K 23.8K 1.23M 41.97%
166 2011 Steven H. Collis President and Chief Executive Officer 834.6K 727.4K 1.33M 1.08M 637.1K 4.61M 44.56%
167 2011 R. David Yost Retired Chief Executive Officer 1.03M 1.78M 180.5K 4.41M 0.00%
168 2011 Michael D. DiCandilo Executive Vice President and Chief Financial Officer 709.4K 666.8K 1.22M 883.7K 97.6K 3.91M 48.15%
169 2011 John G. Chou Executive Vice President and General Counsel 373.7K 257.6K 469.8K 454.0K 51.9K 1.61M 45.27%
170 2011 John G. Chou Executive Vice President, General Counsel and Secretary 373.7K 257.6K 469.8K 454.0K 51.9K 1.61M 45.27%
171 2011 David W. Neu Senior Vice President and President, AmerisourceBergen 412.8K 212.1K 386.9K 441.0K 50.9K 1.59M 37.72%
172 2011 David W. Neu Senior Vice President and President, AmerisourceBergen 412.8K 212.1K 386.9K 441.0K 50.9K 1.59M 37.72%
173 2011 Peyton R. Howell 391.8K 181.9K 331.7K 514.6K 57.9K 1.48M 34.61%
174 2011 James D. Frary Senior Vice President and President, AmerisourceBergen 315.0K 212.1K 386.9K 502.5K 46.4K 1.46M 40.95%
175 2010 R. David Yost Chief Executive Officer 1.26M 583.3K 1.08M 3.52M 155.5K 7.43M 22.36%
176 2010 R. David Yost Retired Chief Executive Officer 1.26M 583.3K 1.08M 3.52M 155.5K 7.43M 22.36%
177 2010 Steven H. Collis President and Chief Operating Officer 652.0K 536.7K 991.9K 1.08M 1.28M 4.66M 32.79%
178 2010 Steven H. Collis President and Chief Executive Officer 652.0K 536.7K 991.9K 1.08M 1.28M 4.66M 32.79%
179 2010 Michael D. DiCandilo Executive Vice President and Chief Financial Officer 673.1K 536.7K 991.9K 1.04M 81.7K 3.47M 44.07%
180 2010 James D. Frary Senior Vice President, AmerisourceBergen Corporation, and President, AmerisourceBergen Specialty Distribution and Services 269.4K 203.2K 408.3K 259.9K 1.54M 13.20%
181 2010 John G. Chou Senior Vice President, General Counsel and Secretary 330.5K 198.3K 366.6K 509.0K 41.2K 1.45M 38.90%
182 2010 John G. Chou Executive Vice President, General Counsel and Secretary 330.5K 198.3K 366.6K 509.0K 41.2K 1.45M 38.90%
183 2009 R. David Yost President and Chief Executive Officer 1.23M 790.4K 1.14M 3.03M 133.7K 7.64M 25.33%
184 2009 R. David Yost Retired Chief Executive Officer 1.23M 370.3K 3.03M 133.7K 6.85M 5.40%
185 2009 R. David Yost Chief Executive Officer 1.23M 370.3K 778.1K 3.03M 133.7K 6.85M 16.76%
186 2009 Michael D. DiCandilo Executive Vice President and Chief Financial Officer 651.4K 325.9K 684.8K 775.9K 70.2K 2.72M 37.14%
187 2009 Steven H. Collis Executive Vice President, AmerisourceBergen Corporation, and President, AmerisourceBergen Drug Corporation 572.7K 377.1K 720.1K 75.5K 2.64M 14.26%
188 2009 Steven H. Collis President and Chief Operating Officer 572.7K 311.1K 653.6K 720.1K 75.5K 2.38M 40.59%
189 2009 Steven H. Collis President and Chief Executive Officer 572.7K 311.1K 653.6K 720.1K 75.5K 2.38M 40.59%
190 2009 Jeanne B. Fisher Senior Vice President, Human Resources 330.5K 212.1K 373.3K 40.1K 1.25M 16.93%
191 2009 John G. Chou Senior Vice President, General Counsel and Secretary 310.2K 94.8K 199.2K 298.6K 34.8K 940.9K 31.25%
192 2009 John G. Chou Executive Vice President, General Counsel and Secretary 310.2K 94.8K 199.2K 298.6K 34.8K 940.9K 31.25%
193 2008 R. David Yost President and Chief Executive Officer 1.18M 459.8K 1.14M 2.72M 129.4K 5.71M 27.96%
194 2008 R. David Yost Chief Executive Officer 1.18M 447.1K 2.72M 129.4K 5.48M 8.16%
195 2008 Michael D. DiCandilo Executive Vice President and Chief Financial Officer, AmerisourceBergen Corporation, and Chief Operating Officer, AmerisourceBergen Drug Corporation 619.2K 355.8K 854.1K 632.6K 63.6K 2.53M 47.91%
196 2008 Michael D. DiCandilo Executive Vice President and Chief Financial Officer 619.2K 375.6K 771.8K 632.6K 63.6K 2.46M 46.59%
197 2008 Steven H. Collis Executive Vice President, AmerisourceBergen Corporation, and President, AmerisourceBergen Drug Corporation 539.8K 338.6K 540.1K 50.0K 2.29M 14.76%
198 2008 Steven H. Collis Executive Vice President, AmerisourceBergen Corporation, and President, AmerisourceBergen Specialty Group 539.8K 338.6K 824.9K 540.1K 50.0K 2.29M 50.73%
199 2008 Steven H. Collis President and Chief Operating Officer 539.8K 357.7K 735.0K 540.1K 50.0K 2.22M 49.16%
200 2008 Jeanne B. Fisher Senior Vice President, Human Resources 321.0K 114.6K 278.1K 316.4K 33.5K 1.06M 36.92%
201 2008 Jeanne B. Fisher Senior Vice President, Human Resources 321.0K 114.6K 316.4K 33.5K 1.06M 10.77%
202 2008 John G. Chou Senior Vice President, General Counsel and Secretary 294.9K 89.4K 183.8K 189.9K 31.0K 788.8K 34.63%
203 2008 John G. Chou Senior Vice President, General Counsel and Secretary 294.9K 65.2K 144.7K 189.9K 31.0K 725.6K 28.93%
204 2007 R. David Yost President and Chief Executive Officer 1.13M 290.7K 853.7K 1.36M 142.9K 4.87M 23.48%
205 2007 R. David Yost President and Chief Executive Officer 1.13M 290.7K 853.7K 1.36M 142.9K 4.87M 23.48%
206 2007 Kurt J. Hilzinger Former President and Chief Operating Officer 676.5K 259.5K 799.2K 809.3K 104.0K 2.82M 37.58%
207 2007 Michael D. DiCandilo Executive Vice President and Chief Financial Officer 569.2K 221.0K 629.6K 653.3K 66.2K 2.28M 37.27%
208 2007 Michael D. DiCandilo Executive Vice President and Chief Financial Officer 569.2K 221.0K 629.6K 653.3K 66.2K 2.28M 37.27%
209 2007 Michael D. DiCandilo Executive Vice President and Chief Financial Officer, AmerisourceBergen Corporation, and Chief Operating Officer, AmerisourceBergen Drug Corporation 569.2K 221.0K 629.6K 653.3K 66.2K 2.28M 37.27%
210 2007 Terrance P. Haas Executive Vice President and Chief Integration Officer 453.1K 204.2K 580.4K 524.4K 49.8K 1.88M 41.74%
211 2007 Steven H. Collis Executive Vice President, AmerisourceBergen Corporation, and President, AmerisourceBergen Drug Corporation 495.4K 210.2K 200.0K 93.5K 1.61M 13.05%
212 2007 Steven H. Collis Executive Vice President, AmerisourceBergen Corporation, and President, AmerisourceBergen Specialty Group 495.4K 210.2K 611.1K 200.0K 93.5K 1.61M 51.00%
213 2007 Steven H. Collis Executive Vice President and President, AmerisourceBergen Specialty Group 495.4K 210.2K 611.1K 200.0K 93.5K 1.61M 51.00%
214 2006 R. David Yost Chief Executive Officer 1.08M 1.59M 470.7K 97.5K 8.8K 3.15M 18.06%
215 2006 Kurt J. Hilzinger President and Chief Operating Officer 647.1K 869.4K 434.5K 90.0K 8.8K 1.96M 26.76%
216 2006 Michael D. DiCandilo Executive Vice President and Chief Financial Officer 519.2K 638.4K 362.1K 75.0K 8.8K 1.53M 28.59%
217 2006 Steven H. Collis Executive Vice President and President, AmerisourceBergen Specialty Group 456.0K 477.5K 344.0K 71.3K 8.8K 1.29M 32.28%
218 2006 Terrance P. Haas Executive Vice President and Chief Integration Officer 397.1K 360.0K 325.9K 67.5K 8.8K 1.09M 36.03%
219 2005 R. David Yost Chief Executive Officer 1.04M 731.3K 170.0K 8.4K 1.78M 9.53%
220 2005 R. David Yost Chief Executive Officer 1.04M 731.3K 85.0K 1.78M 4.79%
221 2005 Kurt J. Hilzinger President and Chief Operating Officer 620.6K 406.3K 283.4K 85.0K 1.31M 28.12%
222 2005 Kurt J. Hilzinger President and Chief Operating Officer 620.6K 406.3K 170.0K 8.4K 1.04M 16.42%
223 2005 Steven H. Collis Senior Vice President and President, AmerisourceBergen Specialty Group 422.3K 466.7K 60.0K 889.0K 6.75%
224 2005 Michael D. DiCandilo Executive Vice President and Chief Financial Officer 460.6K 285.0K 120.0K 8.4K 754.0K 15.92%
225 2005 Michael D. DiCandilo Executive Vice President and Chief Financial Officer 460.6K 285.0K 60.0K 745.6K 8.05%
226 2005 Terrance P. Haas Senior Vice President and President, AmerisourceBergen Drug Corporation 369.2K 206.0K 55.0K 575.2K 9.56%
227 2004 Steven H. Collis Senior Vice President and President, AmerisourceBergen Specialty Group 400.0K 426.1K 60.0K 1.50M 2.33M 2.58%
228 2004 R. David Yost Chief Executive Officer 1.04M 501.5K 170.0K 8.2K 1.55M 10.98%
229 2004 R. David Yost Chief Executive Officer 1.04M 501.5K 85.0K 1.54M 5.52%
230 2004 Kurt J. Hilzinger President and Chief Operating Officer 584.1K 322.9K 170.0K 8.2K 915.2K 18.58%
231 2004 Kurt J. Hilzinger President and Chief Operating Officer 584.1K 322.9K 85.0K 907.0K 9.37%
232 2004 Michael D. DiCandilo Executive Vice President and Chief Financial Officer 348.3K 175.0K 120.0K 8.2K 531.5K 22.58%
233 2004 Michael D. DiCandilo Senior Vice President and Chief Financial Officer 348.3K 175.0K 60.0K 523.3K 11.47%
234 2004 Michael D. DiCandilo Executive Vice President and Chief Financial Officer 348.3K 175.0K 60.0K 523.3K 11.47%
235 2004 Terrance P. Haas Senior Vice President and President, AmerisourceBergen Drug Corporation 309.3K 167.9K 50.0K 477.1K 10.48%
236 2003 R. David Yost Chief Executive Officer 960.4K 995.0K 1.96M 0.00%
237 2003 R. David Yost Chief Executive Officer 960.4K 995.0K 100.0K 1.96M 5.11%
238 2003 Kurt J. Hilzinger President and Chief Operating Officer 549.1K 562.0K 80.0K 1.11M 7.20%
239 2003 Kurt J. Hilzinger President and Chief Operating Officer 549.1K 562.0K 1.11M 0.00%
240 2003 Steven H. Collis Senior Vice President and President, AmerisourceBergen Specialty Group 379.2K 385.0K 40.0K 764.2K 5.23%
241 2003 Steven H. Collis Senior Vice President and President, AmerisourceBergen 379.2K 385.0K 764.2K 0.00%
242 2003 Michael D. DiCandilo Senior Vice President and Chief Financial Officer 331.0K 335.0K 666.0K 0.00%
243 2003 Michael D. DiCandilo Executive Vice President and Chief Financial Officer 331.0K 335.0K 55.0K 666.0K 8.26%
244 2003 Michael D. DiCandilo Senior Vice President and Chief Financial Officer 331.0K 335.0K 55.0K 666.0K 8.26%
245 2003 Terrance P. Haas Senior Vice President, Operations 270.7K 273.8K 544.5K 0.00%
246 2003 Terrance P. Haas Senior Vice President and President, AmerisourceBergen Drug Corporation 270.7K 273.8K 30.0K 544.5K 5.51%
247 2002 R. David Yost Chief Executive Officer 662.5K 694.7K 1.36M 0.00%
248 2002 R. David Yost Chief Executive Officer 662.5K 694.7K 100.0K 1.36M 7.37%
249 2002 Kurt J. Hilzinger President and Chief Operating Officer 428.5K 450.0K 75.0K 878.5K 8.54%
250 2002 Kurt J. Hilzinger President and Chief Operating Officer 428.5K 450.0K 878.5K 0.00%
251 2002 Charles J. Carpenter Senior Vice President and President, PharMerica, Inc. 371.2K 375.0K 746.2K 0.00%
252 2002 Brent R. Martini Former Executive Officer 400.0K 300.0K 700.0K 0.00%
253 2002 Steven H. Collis Senior Vice President and President, AmerisourceBergen 335.0K 335.0K 670.0K 0.00%
254 2002 Steven H. Collis Senior Vice President and President, AmerisourceBergen Specialty Group 335.0K 335.0K 35.0K 670.0K 5.22%
255 2002 Michael D. DiCandilo Senior Vice President and Chief Financial Officer 248.5K 300.0K 50.0K 548.5K 9.12%
256 2002 Michael D. DiCandilo Senior Vice President and Chief Financial Officer 248.5K 300.0K 548.5K 0.00%
257 2002 Terrance P. Haas Senior Vice President and President, AmerisourceBergen Drug Corporation 221.4K 230.0K 25.0K 451.4K 5.54%
258 2002 Terrance P. Haas Senior Vice President, Operations 221.4K 230.0K 451.4K 0.00%
259 2001 R. David Yost Chief Executive Officer 563.9K 642.3K 1.21M 0.00%
260 2001 Kurt J. Hilzinger President and Chief Operating Officer 362.9K 406.1K 769.0K 0.00%
261 2001 Charles J. Carpenter Senior Vice President and President, PharMerica, Inc. 350.0K 335.8K 685.8K 0.00%
262 2001 Brent R. Martini Former Executive Officer 375.0K 230.0K 605.0K 0.00%
263 2001 Steven H. Collis Senior Vice President and President, AmerisourceBergen 300.0K 259.7K 559.7K 0.00%
264 2001 Terrance P. Haas Senior Vice President, Operations 186.7K 231.0K 417.7K 0.00%
265 2001 Michael D. DiCandilo Senior Vice President and Chief Financial Officer 154.6K 189.8K 344.4K 0.00%
266 2000 R. David Yost Chief Executive Officer 525.0K 592.3K 1.12M 0.00%
267 2000 Kurt J. Hilzinger President and Chief Operating Officer 340.0K 370.6K 710.6K 0.00%
268 2000 Brent R. Martini Former Executive Officer 325.0K 124.4K 449.4K 0.00%
269 2000 Charles J. Carpenter Senior Vice President and President, PharMerica, Inc. 300.0K 135.1K 435.1K 0.00%
270 2000 Steven H. Collis Senior Vice President and President, AmerisourceBergen 261.3K 94.1K 355.4K 0.00%
271 2000 Michael D. DiCandilo Senior Vice President and Chief Financial Officer 136.0K 115.0K 251.0K 0.00%
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2026-01-22 DEFA14A
2026-01-22 DEF 14A

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-05-06 8-K
2026-05-06 10-Q
2026-05-05 4
2026-05-05 4
2026-05-05 4
2026-04-29 SC 13G
2026-04-02 4
2026-03-26 SC 13G/A
2026-03-23 8-K
2026-03-17 8-K

Executive team

NameTitleCompensationGender
Robert Mauch President, Chief Executive Officer & Director 6M
James F. Cleary Jr. Executive Vice President & Chief Financial Officer 3M male
Elizabeth S. Campbell Executive Vice President & Chief Legal Officer 2M female
Silvana Battaglia Executive Vice President & Chief Human Resources Officer 2M female
Pawan Singh Verma Executive Vice President and Chief Data & Information Officer male
Richard Tremonte EVP and President of U.S. Pharmaceuticals & Animal Health male
Lazarus Krikorian Senior Vice President, Chief Accounting Officer & Corporate Controller male
François Mandeville Executive Vice President and Chief Strategy and M&A Officer male
Juan Guerra EVP & President of International Business Group male
Bennett S. Murphy Senior VP Of Investor Relations & Enterprise Productivity and Treasury male
ESG Rating
B
MEDICAL - DISTRIBUTION
2025
E (Environmental)
50.0 / 73.2
Company / Sector avg.
S (Social)
72.5 / 63.7
Company / Sector avg.
G (Governance)
64.3 / 59.8
Company / Sector avg.
ESG Total
62.3 / 65.6
Company / Sector avg.
ESG Score History MEDICAL - DISTRIBUTION
Benchmark vs Sector
Political Trading Activity (25M)
Senate Trading Activity
Transaction Date Disclosed Senator State Owner Type Amount Link
2021-11-16 2021-12-04 Thomas R. Carper DE Spouse Sale (Full) $1,001 - $15,000
2021-08-04 2021-09-01 Thomas R. Carper DE Spouse Purchase $1,001 - $15,000
House Trading Activity
Transaction Date Disclosed Representative District Owner Type Amount Link
2026-03-31 2026-05-01 Jared Moskowitz FL23 Purchase $1,001 - $15,000
2026-03-23 2026-05-01 Jared Moskowitz FL23 Purchase $1,001 - $15,000
2025-05-12 2025-06-23 Jefferson Shreve IN06 Sale $50,001 - $100,000
2025-03-27 2025-04-09 Greg Landsman OH01 Spouse Sale $15,001 - $50,000
2024-11-15 2024-12-06 Ro Khanna CA17 Purchase $1,001 - $15,000
2024-10-09 2024-11-14 Michael McCaul TX10 Spouse Purchase $50,001 - $100,000
2024-10-09 2024-11-14 Michael McCaul TX10 Purchase $15,001 - $50,000
2024-05-29 2024-08-14 Greg Landsman OH01 Spouse Purchase $15,001 - $50,000
2024-02-20 2024-03-20 Michael McCaul TX10 Spouse Sale $50,001 - $100,000
2024-02-20 2024-03-20 Michael McCaul TX10 Sale $1,001 - $15,000
2024-01-10 2024-02-05 Ro Khanna CA17 Purchase $1,001 - $15,000
2023-09-06 2023-10-06 Ro Khanna CA17 Spouse Sale $1,001 - $15,000
2023-08-29 2023-09-06 Ro Khanna CA17 Purchase $1,001 - $15,000
2023-06-29 2023-07-11 Ro Khanna CA17 Spouse Purchase $1,001 - $15,000
2023-05-12 2023-06-22 Michael McCaul TX10 Sale $15,001 - $50,000
2023-05-12 2023-06-22 Michael McCaul TX10 Spouse Sale $100,001 - $250,000
2023-03-24 2023-04-07 Ro Khanna CA17 Sale $1,001 - $15,000
2023-03-14 2023-04-07 Ro Khanna CA17 Spouse Sale $1,001 - $15,000
2023-02-10 2023-03-08 Ro Khanna CA17 Spouse Purchase $1,001 - $15,000
2023-01-25 2023-03-02 Diana Harshbarger TN01 Purchase $1,001 - $15,000
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits